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Abstract
This thesis presents a mathematical model of long-term blood pressure control that
explains how latent activation of the sympathetic nervous system in the AngII-salt
model of hypertension can lead to chronic blood pressure elevation without modifying
renal ability to excrete sodium. Previous mathematical models of hypertension were
built on the assumption that such modication is necessary. The model integrates four
major systems of body uid and solute control: the cardiovascular system, kidneys,
microvascular exchange between extracellular and intracellular compartments, and the
sympathetic nervous system. The model excludes two major hypotheses used in previous
mathematical models: the chronic pressure-natriuresis mechanism and the whole-body
autoregulation mechanism; the model adds a hypothesis of slow long-term activation of
the sympathetic nervous system, which acts to increase pressure via increased non-renal
arterial resistances and venous tone. Despite the dierence in assumptions, the model's
predictions agree well with all major classical observations associated with AngII-salt
hypertension, including the pressure-natriuresis phenomenon. Analysis of the model
demonstrates that the pressure-natriuresis curves are projections of a three-dimensional
dynamics driven by both renal and neural control and reect an additive impact of both
controls on blood pressure. Thus, the current interpretation of pressure-natriuresis
curves as the result only of a direct mechanistic impact of arterial pressure on renal
function may not be warranted in some cases of hypertension. The presented model
conclusively demonstrates that AngII-salt hypertension can be maintained without the
sole renal dominance.
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Chapter 1
Introduction
Chronically elevated arterial blood pressure, or hypertension, is a major risk factor in
the development of cardiovascular diseases such as heart failure and stroke. About
a third of the U.S. population and a quarter of the world's population have hyper-
tension. An exaggerated rise in blood pressure in response to increased salt intake,
so-called salt-sensitivity of blood pressure, is of particular clinical importance. About
25% of the normotensive population, and over 50% of the hypertensive population, are
salt-sensitive, which has been shown to be a stronger predictor of death and cardio-
vascular risk, even more than arterial pressure alone [108]. Despite improvements in
medical therapies over the years, normalization of blood pressure is still not achievable
in almost 50% of hypertensive patients. This poor control rate is partially due to the pa-
tient's medication noncompliance, but is also due to an incomplete understanding of the
mechanisms that lead to the development of hypertension. Because of the sheer number
of physiological factors involved in blood pressure regulation, mathematical modeling
plays an important role in identifying which of these factors are signicant.
Existing mathematical models are of limited scientic and clinical impact as they
are incapable of identifying pathways that do not include kidney dysfunction. Recent
eorts have been focused almost exclusively on designing an accurate and detailed model
of kidney function, since kidneys were believed to be the sole culprit of hypertension.
However, the latest experimental and clinical ndings have shown that targeting neural
1
2pathways can be successful in treating hypertension, independent of kidney function.
Since the current models dramatically limit the ability to model the inuence of alter-
nate pathways in the development of hypertension, we build a novel framework for a
mathematical model that includes neural pathways as an independent long-term con-
troller of blood pressure.
1.1 Basics of blood pressure control
There are many mechanisms by which arterial blood pressure may eventually be raised,
but there are only two immediate factors: cardiac output and total peripheral resistance.
Cardiac output, the amount of blood pumped by the heart each minute, creates a pres-
sure gradient between arteries and veins that drives the ow through circulatory system.
By averaging the above variables across a cardiac cycle, Ohm's law representation of
this phenomenon can be expressed as:
Mean Arterial Pressure - Mean Venous Pressure
= Total Peripheral Resistance Cardiac Output:
Since mean venous pressure is near zero, changes in arterial pressure are determined by
peripheral resistance and cardiac output.
Total peripheral resistance and cardiac output are under the control of a larger num-
ber of factors. Activation of the sympathetic nervous system1 and circulating hormones
can increase peripheral resistance by constricting the vascular walls. The sympathetic
nervous system can increase heart rate and cardiac contractility, causing an elevation
in cardiac output. An increase in blood volume and venous tone cause expansion of
the stressed blood volume2 , delivering more blood to the heart, stretching the heart
muscle further, resulting in more vigorous contractions, and thus also increasing cardiac
1 The sympathetic nervous system is one of the divisions of the nervous system, inuencing many
factors of blood pressure control such as heart rate, vascular tone, and sodium excretion.
2 Blood vessels contain a certain volume of blood at a zero transmural pressure, called unstressed
volume. The unstressed volume depends on the diameter of the vessels and thus is modied by vessel
tone, primarily venous tone. The remaining portion of the total blood volume is called stressed volume.
3output. Blood volume can be increased by moving uid from the extravascular space
or by retention of water and sodium. A schematic view of this basic control cascade is
shown in Figure 1.1. A complete list of all factors and mechanisms involved in blood
pressure control is large, with entire books dedicated to the discussion [38, 60]. A sum-
mary based on the diagram proposed by Page [79] is shown in Figure 1.2, with relevant
portions covered in later sections of this dissertation highlighted.
Figure 1.1: Basic sequence of changes leading to an elevation of mean arterial pressure.
1.2 Salt-sensitive hypertension
1.2.1 Direct observations
Studying hypertension in humans is complicated not only because most variables are ex-
perimentally inaccessible, but also because the disease progression usually spans decades
and often goes undiagnosed for years. Thus, hypertension research is often performed in
animals. One of the common rodent models of salt-sensitive hypertension is a chronic
infusion of angiotensin II (AngII) in combination with a high salt diet (AngII-salt).
Angiotensin II is a hormone which plays an important role in blood pressure control
and has a wide range of eects on the vasculature, kidneys, and brain, leading to vaso-
constriction, renal3 sodium retention and an elevation of sympathetic nerve activity.
The magnitude of chronic blood pressure response in the AngII-salt animal model is
3 "Renal" means pertaining to kidney.
4Figure 1.2: A comprehensive summary of factors involved in blood pressure control
modied from [79]. Examples for each factor are provided in parentheses. The graph
is complete, attesting to the notion of multifactorial nature of blood pressure control.
Edges labeled in black denote the connections that are reected in the mathematical
model presented in this dissertation. Specic denitions of the terms can be found later
in text as they are introduced.
directly related to the level of salt4 intake.
A typical arterial pressure response to AngII-salt protocol is shown in Figure 1.3. In
this example, chronic infusion of angiotensin II caused minimal increase in mean arterial
pressure in rats on a low salt diet. However, when animals were placed on normal or
high salt diet, blood pressure progressively increased.
A similar observation has been made in a study performed in dogs by Krieger et
al [62]. After several days of intravenous infusion of angiotensin II, daily salt intake
was increased and the corresponding changes in blood pressure, cardiac output, and
total body weight were measured. Total body weight was assumed to correlate with
the total blood volume; total peripheral resistance was computed as the ratio of arterial
4 Salt is composed primarily of sodium chloride (NaCl). Sodium is the principal osmole in extracel-
lular uid and chloride is its primary anion. The ions are transported in equivalent amounts in most
cases, thus in hypertension literature the terms "salt" and "sodium" are often used interchangeably.
5Figure 1.3: The response of daily averages of the mean arterial pressure (MAP) to
administration of angiotensin II (AngII) started on Day 7 in rats consuming low (0.1%),
normal (0.4%) or high (2.0%) salt diets. Figure from [76].
pressure to cardiac output. As shown in Figure 1.4,A, the combination of high salt
and angiotensin II resulted in the elevation of blood pressure. Initially the elevation
in blood pressure was accompanied by an increase in blood volume and cardiac output
(the onset phase). At the later stage, however, the cardiac output returned to control
levels and only total peripheral resistance was elevated (the maintenance phase). This
temporal pattern of arterial pressure, cardiac output, blood volume, and total peripheral
resistance has been observed in several similar studies, and was stylized by Guyton
as shown in Figure 1.4,B. It is referred to as the hemodynamic prole of AngII-salt
hypertension.
In human hypertension a similar hemodynamic prole has been observed, albeit over
much longer period of time (years) than that which is observed in the animal models. In
mild hypertension, cardiac output is elevated while resistance is normal. In moderate
to severe hypertension, cardiac output is normal but resistance is elevated. Unlike
in Krieger's and Guyton's studies, however, blood volume in hypertensive humans is
reported to be normal or slightly below normal levels.
The mechanisms behind the hemodynamic prole of AngII-salt hypertension have
been debated for decades, in part because angiotensin II has renal, vascular, and neural
6Figure 1.4: Hemodynamic prole of AngII-salt hypertension with two distinct phases:
onset and maintenance. A: Responses of mean arterial pressure, cardiac output, change
in body weight, and total peripheral resistance to increased salt intake in conscious dogs
with high plasma AngII maintained by continuous intravenous infusion. Figure from
[6]. B: Stylized summary of the responses from several similar studies. Figure modied
from [38]. Values show percentage of the normal steady state.
actions, all of which can raise blood pressure via multiple pathways. There are two main
theories that have been proposed to explain the hemodynamic prole: the renocentric
theory and the neurocentric theory.
1.2.2 The renocentric theory
Hypotheses
The renocentric theory was introduced by Guyton in early 1970's. It relies on two
hypothetical mechanisms: chronic pressure-natriuresis mechanism and whole-body au-
toregulation mechanism.
7The chronic pressure-natriuresis hypothesis states that the renal ability to excrete
salt (natriuresis) over long-term is directly determined by the arterial pressure: the
higher the pressure the more salt is excreted. The evolution of this hypothesis is shown
in Figure 1.5. Isolated kidney studies from the 1950's demonstrated that an acute
(within minutes) rise of renal perfusion pressure5 leads to an acute rise in sodium
excretion in an isolated kidney [96, 97, 103]. The dependence of acute sodium excretion
on renal perfusion pressure is known as an acute renal function curve, or acute pressure-
natriuresis curve (Figure 1.5,A). This relationship, however, does not hold long term
[38].
The classical experiment that measured chronic relationship between pressure and
natriuresis was performed by DeClue et al [23] (Figure 1.5,B). In this experiment, two
groups of dogs were studied. In one group, plasma AngII was elevated 2.5 times via
continuous infusion. The other group was used as control. In both groups chronic
sodium and water intake was varied via infusions over the period of few weeks. Arterial
blood pressure and urinary sodium excretion were measured at three day intervals until
these variables reached steady state, and sodium excretion matched the new level of
sodium intake. The results were rst plotted as blood pressure versus sodium intake
and a correlation was noted: an almost zero slope in the control group and a non-zero
slope in the other group. Since sodium intake and excretion were the same at the time
of the measurements, the authors proposed that the correlation could be the sign of a
direct long-term causal relationship between the arterial pressure and sodium excretion.
The axes of the plot were reversed and relabeled (Figure 1.5,C). The resulting curve
is known as the chronic pressure-natriuresis curve, and is used to describe the direct
functional dependence of sodium excretion on arterial pressure in Guyton's theory.
The whole body autoregulation mechanism of peripheral resistance was proposed by
Guyton and his colleagues to help explain the rise in total peripheral resistance during
the maintenance phase of the hemodynamic prole. Guyton did not believe that the
sympathetic nervous system was involved in the long-term regulation of blood pressure
5 Renal perfusion pressure is the pressure in the renal arteries. It is measured further away from
the heart than the arterial pressure and thus lower in magnitude, but can be assumed to be linearly
dependent on the arterial pressure.
8Figure 1.5: Evolution of the pressure-natriuresis hypothesis used as the foundation of
the renocentric theory. A: The dependence of sodium excretion on perfusion pressure on
the scale of minutes and termed as the acute pressure-natriuresis. B: Chronic correlation
between steady states of arterial pressure and sodium intake. C: Same data as B, but
with axes reversed and sodium intake relabeled as sodium excretion. This relationship
is termed as the chronic pressure-natriuresis.
and thus hypothesized that the observed constriction of vessels is due to over-perfusion.
This mechanism is similar to a well-known acute response, called the myogenic response,
where vascular tone is rapidly adjusted within seconds. There is sparse experimental
evidence for the long-term autoregulation mechanism proposed by Guyton, and its ex-
istence remains highly debated [59].
Explanation of AngII-salt hemodynamic prole
Under the above assumptions the hemodynamic prole of AngII-salt hypertension shown
in Figure 1.4 can be explained as follows. The chronic pressure-natriuresis mechanism
9implies that in normal conditions it takes only a small increase in pressure to produce
a large change in excretion, but a disturbance such as the infusion of AngII may reduce
the slope and thus the hemodynamic prole of AngII-salt hypertension would ensue
as follows. At the onset of high salt intake, when arterial pressure is still at a nor-
mal level, the sodium excretion is relatively low which leads to an accumulation of salt
and expansion of blood volume. The latter increases cardiac output (the onset phase)
followed by the over-perfusion of systemic organs which triggers whole body autoregu-
lation mechanism and a rise in peripheral resistance (the maintenance phase). Thus the
arterial pressure rises and continues to rise until it reaches a level necessary to match
salt excretion with salt intake (Figure 1.6).
Additional experimental evidence
There are two often-cited arguments of indirect evidence for chronic dependence of blood
pressure on renal ability to excrete sodium:
1. Hypertension follows transplanted kidney: Several studies of kidney cross-
transplantation between normotensive and hypertensive subjects show that hy-
pertension often follows the kidney [21, 32]. That is, transplantation of kidneys
from normotensive subjects reduces the blood pressure of the hypertensive recipi-
ents and transplantation of kidneys from hypertensive subjects increases the blood
pressure in the normotensive recipients.
2. Natriuresis may be insucient if perfusion pressure is xed: In a study
by Hall et al [44] two groups of dogs received chronic AngII infusion over a couple
of weeks and daily measurements of arterial blood pressure and sodium excretion
were collected. In one group of dogs renal perfusion pressure was clamped, i.e.
xed at a constant normal level, eectively buering the kidney from changes in
the arterial pressure. The other group of dogs was used as a control. The authors
showed that clamping of the renal perfusion pressure led to a severe reduction in
sodium excretion and excessive uid retention, which was resolved only after renal
perfusion pressure was unclamped. It was concluded that a rise in renal perfusion
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Figure 1.6: Basic renocentric concept of chronic blood pressure response to AngII-salt
protocol. The onset phase is due to a shift of the renal function curve in response to
AngII which leads to an insucient sodium excretion for the new elevated level of sodium
intake. This results in blood volume accumulation and increase in cardiac output. The
maintenance phase is sustained by the whole body autoregulation mechanism which
increases peripheral resistance in response to high cardiac output. The system reaches
an equilibrium when arterial pressure is high enough to generate sodium excretion equal
to sodium intake via the renal function curve determined by AngII concentration.
pressure is essential in allowing kidneys to attain sodium balance.
The direct mechanisms governing chronic pressure-natriuresis have not yet been
identied [28, 46]. The kidneys excrete sodium and water by rst ltering large amounts
of uid and solutes and then reabsorbing the majority of them back into the circulation.
Thus there are three fundamental ways by which sodium excretion may change: change
in renal blood ow, change in ltration rate and change in reabsorption rate. It has
been demonstrated that both renal blood ow and ltration rate are eciently regulated
against changes in arterial pressure [89]. So most of the recent studies have been focused
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on the control of the reabsorption rate [20, 33, 68]. However, the question of how the
kidney is able to sense arterial pressure remains unanswered.
1.2.3 The neurocentric theory
Hypotheses
The neurocentric theory has been around for as long as the renocentric theory, but
only recent technological advancements have enabled collection of robust evidence in its
support. The theory relies on two hypotheses: 1) sympathetic nerve activity is elevated
by a combination of high AngII with high sodium intake, and 2) sodium excretion within
a physiologically relevant concentrations does not need to be regulated by the arterial
pressure. The latter hypothesis is a key to distinguishing neurocentric theory from the
renocentric one. Without this hypothesis, Guyton's renocentric theory can be invoked
by claiming that the abnormal sympathetic activity "must in the end somehow modify
the kidney's ability to excrete salt and water for a given level of [blood pressure]" [71].
The neurocentric theory also does not rely on the existence of whole body autoregulation
mechanism.
The neurocentric theory does not state that sodium excretion is entirely independent
of pressure, but rather that the kidney's function is regulated by a variety of hormonal
and physical factors which are capable of regulating sodium excretion with little to no
reliance on arterial pressure within a certain physiological range of sodium intake and
circulating AngII. In the absence of abnormal renal function, hypertension is driven
primarily by elevated sympathetic activity via non-renal pathways. The arterial pres-
sure, however, can become an important controller of sodium excretion in more extreme
conditions when sodium intake is signicantly elevated, other control mechanisms are
overwhelmed, or if the pressure itself is very high.
Explanation of AngII-salt hemodynamic prole
Under the above assumptions, the AngII-salt hemodynamic prole can be explained as
follows. The onset phase is a combination of normal responses to AngII and to salt
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intake, seen in normotensive and hypertensive subjects alike. Increase in salt intake is
matched by renal excretion via hormonal responses, hydrostatic and osmotic forces, but
is somewhat delayed by the elevated AngII which opposes excretion. The 2-3 day delay
of the renal response to sodium intake is thus accompanied by a minor salt and water
accumulation, an increase in blood volume, cardiac output and arterial pressure. This
early rise of blood pressure triggers an acute transient decrease in sympathetic activity
known as the baroreex response. The vasodilation associated with the baroreex masks
the vasoconstriction caused by AngII. Thus total peripheral resistance remains largely
unchanged during the onset phase of AngII-salt hypertension. The maintenance phase
is triggered by a latent chronic activation of the sympathetic nerve activity initiated
by the brain's cardiovascular control center in response to elevated circulating levels
of salt and AngII. The elevated sympathetic nerve activity increases venous tone and
constricts vessels in non-renal vascular beds elevating total peripheral resistance, along
with now unopposed vasoconstrictor eect of AngII.
Experimental evidence
The following experimental evidence is used in support of the neurocentric theory:
1. Elevated sympathetic nerve activity (SNA) has been observed via direct
and indirect measurements of sympathetic activity [29, 34, 57, 104].
2. Increased SNA is not uniformly distributed: splanchnic6 SNA is elevated
[63, 84], renal SNA is decreased [113], and skeletal muscle SNA remains fairly
unchanged [112]. Moreover, renal denervation does not aect the development of
AngII-salt hypertension [58] while splanchnic denervation attenuates its develop-
ment [57, 58].
3. Blocking cardiovascular centers in the brain attenuates AngII-salt hy-
pertension: Lesions of sites in the brain responsive to changes in AngII and
6 Splanchnic is a term used when referring to a subset of systemic circulation consisting of gastric,
small intestinal, colonic, pancreatic, hepatic, and splenic circulations. Splanchnic organs are responsible
for a majority of the total venous capacity.
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Figure 1.7: Basic neurocentric concept of chronic blood pressure response to AngII-
salt protocol. The onset phase is due to the renal component and the maintenance
phase is due to the neural component. Renal mechanisms match sodium excretion to
sodium intake via a complex interaction of intra-renal and extra-renal feedbacks. The
delay in response causes blood volume and thus cardiac output to increase. Neural
mechanisms are activated by a combination of AngII-salt with a several day delay.
Elevated sympathetic nerve activity increases peripheral resistance and venous tone.
plasma sodium were shown to attenuate hypertension [19, 77]. Chronic adminis-
tration of a sodium channel blocker directly into the brain completely reverses the
maintenance phase of AngII-salt hypertension [78].
4. Sodium excretion may not be regulated by arterial blood pressure.
Studies with acute, modest increase of sodium intake either by isotonic or hyper-
tonic solutions showed that natriuresis happens without changes in arterial blood
pressure [3, 11, 85]. A study by Seeliger et al [95] showed that clamping renal
perfusion pressure does not prevent increased natriuresis following isotonic saline
infusion. Furthermore, a study by Reinhardt et al [86] showed that clamping renal
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perfusion pressure in an AngII-salt model of hypertension does not prevent the
needed increase in natriuresis and thus the natriuresis is regulated by factors other
than arterial pressure. The study by Reinhardt is in direct contradiction with the
study by Hall et al [44] used to support the renocentric theory.
5. There is no evidence of renal dysfunction in most cases of human hyper-
tension, in fact renal abnormality is usually observed only after years of exposure
to high blood pressure [60].
1.2.4 Mathematical models
Mathematical modeling can be useful to hypertension research in at least three ways.
First, it oers a single framework in which all relevant physiological mechanisms and
hypotheses are expressed and allows identication of various pathways leading to the
same set of experimentally observed variables. Second, it generates new hypotheses
that may not be apparent from the experimental data. Third, it provides a tool for
designing future experiments. The latter characteristic also determines future revisions
of the model's hypotheses, in particular if its predictions contradict new experimental
evidence.
The renocentric theory is supported by the mathematical model designed by Guyton
and Coleman. The basic concept described in Figure 1.6 consisted of just a handful of
equations and was rst published in the late 1960's [39], followed by a more extensive
model with more detailed organ function description in the early 1970's [41]. A full
mathematical description of the Guyton-Coleman model (GC model) and parameter
identication has never been published and instead a owchart of the entire system was
provided (Figure 1.8). However, this has not prevented publications of the improvements
to the model's various elements over the years [47, 49, 55].
The improvements and increasing complexity of later versions of the GC model have
not changed the basic premise of the theory, i.e. the chronic pressure-natriuresis is still
the key mechanism which controls the emergence of hypertension in the model. The
model was created not just for the study of hypertension but of other diseases (e.g.
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Figure 1.8: Guyton-Coleman's mathematical model of long-term blood pressure control
as published in 1972 [41].
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heart failure) and responses to various stimuli (e.g. temperature, exercise), thus many
of its details are unimportant for the discussion of hypertension onset. In fact, most of
the current publications with references to the GC model still describe it via its basic,
simplest form similar to the one shown in Figure 1.6 [49, 71].
Even though the renocentric theory heavily relies on the existence of the pressure-
natriuresis mechanism, its description in the GC model has not withstood the test of
time. In the version published in 1972 (Figure 1.8) the arterial pressure increases renal
blood ow and ltration rate in order to increase sodium excretion. As mentioned
previously, it has been shown experimentally that both renal blood ow and ltration
rate are eciently regulated against changes in arterial blood pressure. Thus, changes
in sodium excretion cannot be modeled in such a direct manner and should be instead
controlled via renal reabsorption rate, if they are dependent on arterial pressure at all.
This weakness in the model has focused most of the recent work on the improvement
of the GC's renal function description [47, 48, 55, 72, 100]. The new models can be
roughly divided into two categories: models of renal function alone, and integrative
models where renal function interfaces with the circulation and the sympathetic nervous
system. The former models describe renal processes in great physiological detail, but
lack clear explanation on the direct role of arterial pressure. The latter models have a
simpler representation of renal function and assume that either the arterial pressure or
renal sympathetic activity triggered by changes in the arterial pressure directly modify
renal reabsorption rate. However, this assumption still needs to be vetted by direct
experimental evidence and more detailed mathematical models.
Integrating a physiologically-based model of renal function with a model of the
circulatory system is a big challenge, which explains why the two renal model categories
above exist. The kidneys sense changes in sodium and water intake indirectly, via
changes in the extra-renal responses to dietary inputs (such as osmotic pressures, plasma
composition and circulating hormones). At the same time, the kidneys modify those
responses by modifying total body water and sodium. This complex interaction is
dicult to model, requiring either a simple renal model or a simple representation of
sodium sensing. A more detailed discussion can be found in Chapter 2, Section 2.5.
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All existing mathematical models of long-term blood pressure control are based on
the GC model. No mathematical models in support of the neurocentric theory, which
we are aware of, have been proposed prior to publications based on our work [6, 7, 75].
1.3 Thesis aims
The goal of the current research was to build a mathematical model of long-term blood
pressure control consistent with the neurocentric theory, that is able to explain the
hemodynamic prole of AngII-salt hypertension in rats by chronic activation of the
sympathetic nervous system in the absence of a chronic pressure-natriuresis mechanism.
It is a signicant eort to incorporate all known mechanisms of blood pressure control
(Figure 1.2). The rst version of Guyton's model took several years and an eort of at
least three people. Improvements to the model have been made over several decades, by
dozens of scientists working in teams. The model presented in this dissertation aims not
to compete in size and detail to the GC model but to complement it with a qualitatively
dierent framework which allows study of non-renal causes under the assumption of a
normal renal function. This framework can serve as a foundation for future work which
can extend these ndings, much as the GC model has done for the renocentric research
for more than 5 decades.
The assumption of pressure-natriuresis dependence in the GC model is often incor-
rectly interpreted as mathematical evidence that the hemodynamic prole of AngII-salt
hypertension cannot occur unless the pressure-natriuresis mechanism exists. We have
recently demonstrated that this is not true. Natriuresis can be controlled independently
of arterial pressure, and yet hypertension can still develop [6]. This was an important
step toward the overall goal of developing a neurocentric model of hypertension, but it
has also raised a question of how the kidney is able to sense changes in sodium intake
in the absence of pressure dependence. The answer to this question requires a more de-
tailed mathematical model which includes renal function and key physiologic pathways
aected by sodium and AngII.
The choice of physiological mechanisms and variables to be included in the model
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was driven by identifying the strongest known contributors to blood pressure control and
their known physiological impact. The simplest possible representation was preferred
to keep the size of the model manageable. This approach led to the identication of
four major modules of the model, representing circulatory system, uid-solute exchange
between vascular and extravascular spaces, renal function, and the sympathetic nervous
system (Figure 1.9). The rst two modules (Chapter 2, Sections 2.2 and 2.4) were based
on the previously existing models used in simulations of acute responses. The model
of chronic activation of the sympathetic nervous system (Chapter 2, Section 2.3) was
based on the experimental evidence and the hypotheses of the neurocentric theory. One
important note is that a portion of the sympathetic module acts on a slow time scale
due to known latent activation (Figure 1.7), while the rest of the system acts on a faster
time scale.
Figure 1.9: A schematic representation of the overall model representing four physio-
logical contributors to blood pressure control: circulation, extravascular space, kidneys,
and the sympathetic nervous system (blocks with white background). Direct interac-
tions are shown by arrows. All interactions are on the fast time scale (solid lines) except
for those with the sympathetic nervous system which acts on a slow time scale (dashed
line). The AngII and sodium intake directly aect only the circulatory system. They
cause changes in plasma composition, hydrostatic pressures, and ows which then im-
pact the other three systems. In return, each of them can change parameters of the
circulatory system (e.g. blood volume or resistance) and thus impact the mean arterial
blood pressure.
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The renal function module (Chapter 2, Section 2.5) is the most complex and novel
module of the entire model. What makes it unique is that it combines the following
features: it represents renal sodium and water excretion in moderate detail, it works
together with the circulatory module and uid-solute exchange module to adjust sodium
excretion to sodium intake, and it does not rely on arterial pressure or a direct sensing
of sodium intake to modify the excretion. Thus it addresses the challenge currently
faced by the current models of renal function, as described in the section above.
Simulations in Chapter 3 show that the new model produces a hemodynamic pro-
le of AngII-salt studies consistent with the experimental observations. The pressure-
natriuresis relationship still exists in the new model but as a correlation of two largely
independent variables responding to physiological stimuli by way of two dierent control
pathways. Pressure is raised via a neural pathway in response to the combined stimuli
of AngII and salt, and natriuresis is raised via a renal response to increased salt intake.
A simple mathematical example of this behavior can be demonstrated via the following
system of two variables x1 (mean arterial pressure) and x2 (sodium excretion) with an
input parameter p (sodium intake):
dx1
dt
= f(p)  x1
dx2
dt
= p  x2
While the two variables are determined independently by p, one can express a depen-
dence using their steady state values: x1 = f(x2). Figure 1.10 demonstrates the concept
behind pressure-natriuresis in the new model in its extreme, when the two controls are
decoupled.
Model parameters were chosen based on the available experimental data. Not all
mechanisms can be assessed experimentally, and in particular, the specic measurements
of responses to AngII-salt protocol are limited, so some of the parameters were t using
the best available information on directional change or other mathematical models.
This approach resembles the approaches by other researchers in this eld [41, 47, 55].
However, we have added global sensitivity analysis given the large uncertainty in many
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Figure 1.10: An illustration of how the pressure-natriuresis phenomenon emerges under
the assumptions of the neurocentric theory. Steady state values of mean arterial pressure
and sodium excretion are plotted in response to sodium intake and AngII. Sodium intake
and excretion are shown in normalized units (n.u.). Two of the three orthogonal planes
represent physiological mechanisms of control: sodium excretion is matched to sodium
intake by renal mechanisms and arterial pressure is driven by the sympathetic nervous
system sensitive to sodium intake and AngII, where AngII aects the slope of the curve.
The projection of the resulting 3-D curve onto the plane of mean arterial pressure versus
sodium excretion is the pressure-natriuresis phenomenon observed experimentally. The
plane itself does not reect a direct mechanistic relationship between sodium excretion
and pressure.
of the parameters. It helped identify key parameters and mechanisms responsible for
arterial pressure control in this model. The results of this analysis are shown in Chapter
3.
Finally, in Chapter 4, conclusions from model's analysis and future directions are
discussed. One of the main contributions of this work is the creation of a framework
for testing and comparing various pathways, renal or non-renal, which may be involved
in AngII-salt hypertension. As of today, a number of experimental and clinical eorts
have been used to target the neural component of blood pressure regulation. Yet in
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mathematical modeling, virtually all current work is focused on improving models of
renal function to be t into the framework of the GC model. However, no matter how
accurately one models an organ's function, if its interactions with the rest of the sys-
tem are limited by a narrow assumption such as the pressure-natriuresis mechanism,
all conclusions may be of questionable scientic and clinical merit. And if renal dys-
function is not the single culprit of hypertension, or if arterial pressure does not drive
sodium excretion, then there are missed opportunities to look for treatments outside
of the kidneys with the help of a mathematical model. The outcome of the presented
research addresses this limitation and provides mathematical modeling support for the
neurocentric theory. This neurocentric mathematical model may in turn yield future
clinical benet by providing a tool for clinicians and scientists to better understand the
important physiologic factors that regulate long-term blood pressure levels.
Chapter 2
Mathematical model of long-term
blood pressure control
The diagram in Figure 2.1 shows the "big-picture" view of how arterial pressure is con-
trolled by the mathematical model presented in this chapter. The system consists of
four major control modules: a circulatory module, a neural module, a renal-hormonal
module, and a whole-body exchange module. Arterial pressure is the output of the Cir-
culatory Module, which describes how total blood volume is circulated and partitioned
by the vasculature. It has four key parameters that regulate arterial blood pressure:
heart rate, extra-renal resistance, venous capacitance, and total blood volume. The rst
three parameters are driven by the Neural Module, which senses circulating plasma os-
molality and angiotensin II. The fourth parameter, total blood volume, is determined by
the Whole-Body Exchange Module; this module denes how total body water, sodium
chloride, and proteins are distributed across cells, interstitium, and vascular spaces
and is based on fundamental laws of microvascular transport and lymphatic mecha-
nisms. The Whole-Body Exchange Module also generates key inputs for the Renal
and Hormonal Module, such as plasma protein concentration, plasma osmolality, and
hematocrit. Together with arterial and venous pressure these inputs control sodium and
water excretion, as well as plasma angiotensin II, closing the loop between the modules.
The Renal Module is designed to generate urinary excretion rates via an indirect
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Figure 2.1: Modular owchart of the entire system. The four modules (white back-
ground, large bold italics) are indicated with their main inputs and outputs (grey, bold
font). There are three inputs to the system: sodium intake, water intake, and an-
giotensin II infusion (grey, plain font).
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sensing of sodium and water intakes and does not rely exclusively on vascular pressures.
This module is a novel contribution to the eld both as a stand-alone model and as
a part of the entire system, as it allows a new framework for studying arterial blood
pressure control.
The Neural Module consists of two controls: the traditionally known baroreex con-
trol which acts on the same time scale as the rest of the system and the hypothesized
latent control which acts on a much slower scale. Thus, for simulations and analy-
sis (Chapter 3) the entire system is split into a fast and slow subsystems by way of
time scale separation technique. The fast system contains all but one equation ((2.14))
and represents the early, onset phase of AngII-salt hypertension. The slow activation
presented by Equation (2.14) acts on the steady states of the fast subsystem by mod-
ifying three key parameters of the Circulatory Module: resistance, venous tone and
heart rate. The dynamics of the slow subsystem simulates the maintenance phase of
AngII-salt hypertension (see Figure 1.4).
2.1 Notation and parameters
The approach to parameter identication used in this model resembles the approaches
of others in the eld [47, 55, 41, 107]. Experimental ndings collected from experimental
literature are combined with functions borrowed from parts of the existing models. Data
from non-rodent species was used if no other sources available, after proper scaling.
The description of all system variables is given in Table 2.1 (names) and Table 2.2
(subscripts). Table 2.5 shows normal steady-state values of key system variables and
parameters as well as their source (e.g. a reference or the equation used to compute it).
The normal steady-state value is denoted by subscript 0. For example, cardiac output's
normal value is CO0 = 74 ml/min.
The system has a fair number of parameters many of which have either a common
notation or describe a specic physiological quantity. However, the model contains many
phenomenological relationships for which parameters were tted to experimental data
or adopted from previously published models. Due to a large number of parameters of
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the latter type, and, to avoid cumbersome notation we reuse the same notation (p1, p2
and so on) in each equation and list the parameter values in a corresponding row of the
Table 2.3. The units of these parameters are not explicitly shown, but were matched to
the units of the corresponding variables in the equation (see Table 2.5).
For example, equation (2.5) describes cardiac output as follows:
CO = HR  SV = HR  (p1   p1
1 + ep2(PV  p3)
)
where HR is heart rate, SV is stroke volume, PV is venous pressure, and pi's are param-
eters describing a phenomenological relationship between venous pressure and stroke
volume, known as the Frank-Starling law. From Table 2.3 and units of PV and CO one
can nd that p1 = 0:5 ml, p2 = 0:8 mmHg
 1, and p3 = 0:665 mmHg. The parameters
are also consistent with the normal steady-state values of the variables, that is
CO0 = HR  (p1   p1
1 + ep2(PV;0 p3)
)
where HR = 400 beats per minute (Table 2.4), CO0 = 74 ml/min, and PV;0 = 0 mmHg
(as listed in Table 2.5).
When it is necessary to distinguish among parameters of several functions which use
the above notation, the expanded notation is used by appending the variable's name
(rst column of Table 2.3) to subscript of that parameter, for example pCO;1.
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[X]Y Concentration of substance X in compartment Y
Ald Aldosterone
AngII Angiotensin II
ANP Atrial natriuretic peptide
AVP Vasopressin
BF Blood ow
C Vessel compliance
CO Cardiac output
d Arteriolar diameter
GFR Glomerular ltration rate
h Half-life constant
H hematocrit
HR Heart rate
JX;Y Z Transmembrane ow of substance X from Y into ZbJX;Y Z Luminal ow of substance X from Y into Z
K Permeability surface-area product coecient
M Rate of hormone secretion
Nn Total number of nephrons
NaCl Sodium chloride content
Osm Total small ion content
P Hydrostatic pressure
Q Protein content
R Vessel resistance
SNA Sympathetic nervous activity
V Volume
 Sensitivity of sympathetic nerve activity
 Fraction of reabsorbed NaCl
 Relative apparent blood viscosity
 Fraction of reabsorbed water
 Oncotic pressure
 Reection coecient
 Time constant
Table 2.1: Variable and parameter names.
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A aerent, or arterial
AL ascending limb
AngII angiotensin II
Av available
B blood
b basal
C capillary (extra-renal)
d delay
DL descending limb
DN distal nephron
E eerent
exc excitatory
G glomerular
I intake
IF interstitial uid space
inh inhibitory
NaCl sodium chloride
P plasma
PT proximal tubule
Q protein
R renal, or reabsorption (for KR)
RBC red blood cells
S extra-renal
Str stressed
T total
TC tissue cells
U urine
Unstr unstressed
V uid, or venous (depending on the context)
Table 2.2: Variable and parameter subscripts.
28
Variable Equation p1 p2 p3 p4 p5
CO (2.5) 0.5 0.8 0.665
dAS (2.12) 40.1 1.1 -0.2 29.513 12
dA (2.68) -0.01 -0.043
dE (2.69) 0.15 -0.014bJV,IF-P (2.38) 0.045 1 0.61
MAld (2.76) 2.2 0.01 15 0.35 20.57
MAngII (2.72) 50 -43.2 0.014 24
MANP (2.74) 200 100
MAVP (2.78) 27.8
PIF (2.32) 6 12 4 66.48
RVR (2.70) 2.3456 0.5
VIF,Av (2.35) 47.9 1.3
VUnstr (2.8) 0.5
AL (2.63) 0.8 0.4 -0.5 21.87
DN (2.64) 0.98 0.48 -3.33
DN (2.62) 0.5 0.38 0.12
Table 2.3: Generic parameters of the system's phenomenological functions.
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Parameter Value Units
DL 0.55
R,IF   PR,IF 5.197 mmHg
Q 0.988
OsmTC 24.4886 mOsm
OsmRBC 1.8737 mOsm
CA 0.0092 ml/mmHg
CR 0.1473 ml/mmHg
CS 0.2062 ml/mmHg
CV 0.313 ml/mmHg
HR 400 beats/min
hAngII 40 min
hANP 250 min
hAld 250 min
hAVP 20 min
KC 0.0083 ml/mmHg/min
KG 3:3  10 6 ml/min/mmHg
KQ 0.005 ml/min
KR 3:3  10 6 ml/min/mmHg
KS 25 ml/min
Nn 60000
PPT 5.0126 mmHg
QT 2.3342 g
RAS;b 0.5824 mmHg.min/ml
RCS 0.0206 mmHg.min/ml
RVR 2.3456 mmHg.min/ml
RVS 0.1857 mmHg.min/ml
RA;b 87849 mmHg.min/ml
RE;b 30000 mmHg.min/ml
Table 2.4: Other parameters of the system equations.
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Variable Value Source
Ald, pg/ml 5 [70]
AngII, pg/ml 18 [14]
ANP, pg/ml 100 [54]
AVP, pg/ml 1 [88]
dAS, m 40 [12]
CO, ml/min 74 [22]
HA 0.45 [22]
[NaClP], mOsm/ml 0.282 [22]
IF, mmHg -0.8565 [37]
[Q]P , g/ml 0.0693 [22]
QT , g 2.33 [22]
JNaCl,I-P, mOsm/min 0.0011 (1.6 mOsm/day) [78]
JV,I-P, ml/min 0.0208 (30 ml/day) [22]
SNA, n.u. 0 Assumed
PA, mmHg 100 [22]
PG, mmHg 45 [73]
PV , mmHg 0 [22]
NaClIF, mOsm 18.93 [22]
RBF, ml/min 9.2 [22]
VB, ml 15 Equation (2.7)
VIF, ml 66.4 [22]
VTC, ml 85.2 [22]
VRBC, ml 6.57 [22]
VUnstr, ml 8 [80]
Table 2.5: Normal values; n.u., normalized units. See Tables 2.1, 2.2 and text for
denition and explanation of terms.
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2.2 The circulatory module
2.2.1 Modeling objectives
Understanding the long-term dynamics of arterial pressure requires a model of the con-
trolled circulatory system. Thus, the mathematical model of circulatory system is re-
quired to meet at least the following conditions:
1. It represents sucient detail of the controlled systemic circulation of a normal,
resting, conscious, rat suitable for the study of long-term hemodynamics.
2. It reects uid volume exchange with external environments via ltration into
interstitial space and lymphatic1 return, dietary uid intake, and renal excretion.
3. It allows study of the overall eects of AngII and sympathetic nervous system on
arterial pressure.
2.2.2 Model formulation
The model of circulatory system which ts the modeling objectives is based on the
lumped-parameter windkessel approach widely used in cardiovascular modeling. This
approach is especially useful for designing a model of the entire circulation as it combines
moderate accuracy of system representation with the relatively small set of parameters
that can be identied from experimental data. The lumped-parameter models are used
on both short-time scales, such as the response to hemorrhage, baroreceptor stimulation,
and postural change [74, 106, 105], and long-term scales such as the Guyton-Coleman
model [40].
Our previously published circulatory model [6] is adapted to represent the interac-
tions of the Circulatory Module with other modules and ensure the correct mass balance
for the entire system (Figure 2.1). The total blood volume is distributed among four
capacitive vascular compartments: the arteries, the renal vascular bed, the extra-renal
vascular beds, and the large veins such as inferior and superior vena cava (Figure 2.2).
1 The lymphatic system is a network of vessels that carry a clear uid called lymph extracted from
the interstitial spaces back into great veins of the circulatory system.
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Each of the two vascular beds is preceded by a capillary bed where uid ltration into
the interstitial space (extra-renal bed) or the bladder (renal bed) occurs. The pulmonary
circulation is omitted and the heart is represented by a continuous non-pulsatile pump
which moves blood from the venous to the arterial side of systemic circulation.
The chosen compartment partition allows for the simplest representation of the circu-
latory dynamics of the vascular space and uid volume exchange with the extra-vascular
spaces. The renal vascular bed represents the vasculature structure of the Renal Module
and accounts for the loss of water from the system by modeling glomerular ltration
and tubular reabsorption (see Section 2.5). The extra-renal compartment represents
all other vascular beds of the circulation lumped into one. It is much larger than the
renal compartment in its contribution to total compliance, resistance, and volume, and
all of the water intake and exchange with interstitial space is assumed to occur in the
extra-renal compartment only. The major veins receive the lymphatic return from the
Whole-Body Exchange Module as well as the ingested water intake. Thus, the extra-
renal and venous compartments interface with the Whole-Body Exchange Module (see
Section 2.4) to account for the remaining uid shifts to and from vascular space.
We arrive at the model by requiring that the change of volume in each compartment
is equal to the dierence of its total inow and outow. Volume of each compartment
(V ) is assumed to be linearly dependent on its pressure (P ): V = VU + C  P where
VU is the unstressed volume of the compartment and C is its compliance. The ow (F )
between vascular compartments is driven by the pressure gradient and impeded by the
resistance (R) between the compartments: F = PR . The only exception to the above
is cardiac output, the ow from the venous to the arterial compartment generated by
the heart. Thus, the following equations represent the circulatory module dynamics:
CA  dPA
dt
= CO  PA   PC
RAS
  RBF (2.1)
CS  dPS
dt
=
PC   PS
RCS
  PS   PV
RV S
(2.2)
CV  dPV
dt
=
PS   PV
RV S
+ bJV,IF-P + JV;I P +RBF  JV;P U   CO (2.3)
VStr = CA  PA + CS  PS + CR  PR + CV  PV (2.4)
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Figure 2.2: Fluid ow (arrows) in the Circulatory Module and the interactions with the
other modules of the system. Total blood volume is distributed among four systemic
vascular reservoirs. Blood is circulated via a cardiac pump modeled as a nonlinear
Frank-Starling relationship between venous pressure and cardiac output. P, pressures;
R, hydraulic resistances; C, compliances; CO, cardiac output; A, arteries; V, veins;
C, capillaries; G, glomerulus; AS, extra-renal arteries; CS, extra-renal capillaries; VS,
extra-renal veins; AR, renal aerent arterioles; ER, renal eerent arterioles; VR, renal
veins. The pulmonary circulation is omitted. The Circulatory Module exchanges uid
ow with the Renal Module via glomerular ltration and tubular reabsorption and
with the Whole-Body Exchange Module via capillary ltration rate, water intake, and
lymphatic return.
where CA, CR, CS , and CV are the compliances of arterial, renal, extra-renal, and venous
compartments, respectively; PA, PS , PR, and PV are the hydrostatic pressures in the
above compartments; PC is the extra-renal capillary pressure; RAS , RCS , and RV S
are the extra-renal arterial, capillary, and venous resistances; RV R is the renal venous
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resistance; VStr is the total stressed blood volume; and JV;I P , JV;P U , and bJV,IF-P
are the water intake, urinary water excretion, and lymphatic return, respectively (see
Section 2.4 for details).
The cardiac output (CO) is a product of heart rate (HR) and stroke volume where
stroke volume is expressed as a logistic function of venous pressure, according to the
Frank-Starling law ([36, 91]):
CO = HR  (p1   p1
1 + ep2(PV  p3)
) (2.5)
where p1 is the maximal stroke volume, p2 and p3 describe cardiac contractility.
A portion of the total blood volume (VB) which lls the circulatory system to max-
imum capacity without increasing transmural pressure is called the total unstressed
blood volume (VUnstr). The remaining portion is called the total stressed blood volume:
VStr = VB   VUnstr (2.6)
where the total blood volume VB is the sum of plasma volume VP and red blood cell
volume VRBC (see Section 2.4):
VB = VP + VRBC (2.7)
The total unstressed blood volume, or venous capacitance, of the system is modu-
lated by the sympathetic nerve activity via change in venous tone:
VUnstr = VUnstr;0   p1  SNA (2.8)
where p1 is the sensitivity of venous smooth muscle to sympathetic stimulation and its
value chosen based on data from [99].
Note that the dierence between inow and outow from the extra-renal capillary
bed PA PCRAS  
PC PV
RCS
is the capillary ltration rate JV,P-IF driven by capillary perfusion
pressure PC as well as other forces described in detail in Section 2.4.
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The renal blood ow (RBF) is the net sum of all individual nephron blood ows:
RBF = BFA Nn (2.9)
and the urinary water excretion (JV;P U ) is the net outow from all renal distal tubules:
JV;P U = JV;DN Nn (2.10)
(see Section 2.5 for details).
Note, that we avoid expressing renal blood ow as PA PRRAR where RAR is an arterial
renal resistance. In the renal bed, the resistance to ow is the result of glomerular l-
tration out of the circulation followed by tubular reabsorption back into the circulation,
thus combining vascular and membrane transports (Figure 2.2). See Section 2.5 for
details on the modeling of uid transport through the kidneys.
Arteriolar resistances in the model are modeled via Hagen-Poiseuille's law:
R =
8l
r4
where l is the length of the arteriole, r is its radius, and  is blood viscosity which
is hematocrit2 dependent. At low-vessel diameter, blood viscosity becomes strongly
dependent on the hematocrit of the local blood ow, known as a Fahraeus-Lindqvist
eect [83]. The phenomenon is called relative apparent blood viscosity. Thus, the
extra-renal arteriolar resistance is modeled as
RAS = RAS,b  (HA; dAS)
(0; dAS,0)
 d
4
AS,0
d4AS
(2.11)
where dS is the average arteriolar diameter, HA is the arterial hematocrit, and RAS;b
is the total resistance at basal arteriolar diameter dAS,0 = 40m and zero hematocrit.
The details on the modeling of the relative apparent blood viscosity  as well as renal
aerent and eerent arteriolar resistances can be found in Section 2.5.3.
2 Hematocrit is the ratio of the volume of red blood cells to the total volume of blood.
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The extra-renal arteriolar diameter (dAS, in microns) is assumed to be controlled by
the plasma angiotensin II concentration (AngII) and sympathetic nerve activity (SNA).
Sympathetic nerves in a normal state exert certain tonic vasoconstriction which can
be withdrawn or further activated by lessening or increasing SNA, thus we assume a
linear dependence of the diameter on SNA. Normal levels of AngII exert almost no
vasoconstrictive eect on the vessels, so that further decrease of AngII has little to no
eect on arteriolar diameter. Doubling of AngII plasma concentration exerts maximal
vasoconstrictive eect. Thus we assume a logistic function form of arteriolar diameter
dependence on AngII:
dAS = p1   p2
1 + ep3(AngII p4)
  p5  SNA (2.12)
where the coecients are derived from the overall qualitative behavior described above
and assuming that the eect on resistance RAS is limited by about 50-200% of its normal
value, given general experimental observations of hemodynamic behaviors.
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2.3 The neural module
2.3.1 Modeling objectives
The neurocentric theory assumes that the sympathetic nerve activity is comprised of a
long-term slow time scale component and a transient fast scale component. The sympa-
thetic nerve activity (SNA) aects parameters of the circulatory system and therefore
modies arterial blood pressure. While SNA is capable of modifying renal excretion as
well, its role in the development of AngII-salt hypertension has been refuted by the ex-
perimental evidence (see Chapter 1). Thus, the mathematical model of SNA is required
to meet at least the following conditions:
1. Activation of the sympathetic nerve activity is triggered by long-term (several
days) elevation of plasma sodium and AngII.
2. The well-known short-term (minutes) neural control of circulation via baroreex
is represented.
3. Long-term and short-term sympathetic nerve activity modies the parameters of
the circulatory system only.
2.3.2 Model formulation
According to the neurogenic theory, the control of the sympathetic nerve activity is com-
prised of two major mechanisms acting on dierent time scales: baroreex mechanism
and long-term activation mechanism. Baroreex is a well-known sympathetic response
to arterial pressure elevation and is a mechanism that acts on the time scale of minutes
to hours. The other mechanism is a proposed hypothetical mechanism based on the
indirect evidence suggesting activation of sympathetic response after days of elevated
plasma sodium and AngII (see Chapter 1). Both responses are merged by a group of
neurons in the brain into a set of neural responses sent to the body organs via dierent
neural projections in the spinal cord.
A simplied depiction of the neural pathways thought to be involved in the genera-
tion of the sympathetic nerve outow of AngII-salt hypertension is shown in Figure 2.3.
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Clusters of nerve cell bodies within the brain form specialized centers for processing in-
puts from external sources or other clusters. Mapping all neuronal interactions between
all known central cardiovascular brain centers is an area of on-going investigation.
Figure 2.3: Hypothetical neural pathways involved in the generation of sympathetic
nerve control of three circulatory parameters via four major brain cardiovascular cen-
ters: NTS -nucleus tractus solitarius; PVN - paraventricular nucleus; RVLM - rostral
ventrolateral medulla; and SFO - subfornical organ. Excitatory signals are shown as
solid lines, inhibitory signals are shown as dashed lines. See text for details.
The generation of both fast and slow sympathetic responses occurs via at least four
cardiovascular brain centers: NTS -nucleus tractus solitarius; PVN - paraventricular
nucleus; RVLM - rostral ventrolateral medulla; and SFO - subfornical organ. Changes
in mean arterial pressure are continuously monitored by various sensors in the body, pri-
marily by mechanical stretch receptors in the carotid arteries and aorta, termed barore-
ceptors. The sensory information from the baroreceptors enters NTS, which converts
an excitatory input into an inhibitory signal to RVLM. RVLM generates a sympathetic
outow via several parallel neuronal projections into the spinal cord and then body
organs. Inhibitory pattern of RVLM response includes a decreased arteriolar resistance,
venous tone, and heart rate. The excitatory pattern of RVLM response yields changes
in the opposite direction. Long-term exposure to elevated pressure leads to reduced
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sensitivity of baroreceptors, such that the excitatory signal to the NTS disappears after
1-2 days of elevated blood pressure. This phenomenon is known as the baroreceptor
resetting.
Circulating AngII and sodium are sensed by several cardiovascular brain centers,
which have a weak blood-brain barrier. One of them is the subfornical organ (SFO). It
is believed that a combination of both elevated AngII and plasma sodium are needed in
order to trigger a response of SFO [77]. The neurons from SFO relate the signal to PVN
and then RVLM. Activation of RVLM neurons is delayed and need a sustained elevation
of the excitatory inputs from PVN. When all three inputs to the brain (plasma sodium,
AngII and mean arterial pressure) are elevated during AngII-salt protocol, the inhibitory
pattern of RVLM response is initially dominated by the baroreex pathway. After the
baroreex mechanism resets the excitatory pattern of RVLM response emerges.
In the Neural Module the sympathetic nerve activity is modeled as the net sum of
the two responses:
SNA = SNAexc + SNAinh
where SNAexc is the slow excitatory response and SNAinh is the fast inhibitory response,
with both responses expressed in dimensionless units.
The sympathetic nerve activity modies two parameters of the Circulatory Module:
venous capacitance (VUnstr) and the arteriolar diameter of the extra-renal bed (dAS),
shown in equations (2.8) and (2.12), respectively. We assume that each of the two
parameters responds instantaneously and linearly to the sympathetic input.
Baroreceptor reex is a mechanism that provides short-term regulation of blood
pressure via sensing arterial pressure by sensory receptors, translating it to the NTS
center of the brain, where it is then formed into the eerent sympathetic nerve activity
(SNAinh). According to the experimental evidence [61], the baroreex response is ac-
tivated within a few minutes of elevation of the mean arterial pressure (PA) and then
resets within 48 hours if the elevation is sustained. The relationship between the sym-
pathetic nerve activity and arterial pressure is well approximated by a sigmoid curve.
During resetting, the center of this curve shifts toward new level of sustained arterial
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pressure (Figure 2.4). This dynamics can be modeled as:
SNAinh = 1  2
1 + e 0:5(PA x)
(2.13)
with
dx
dt
=
PA   x
240
Here, SNA is expressed in dimensionless units, ranging between -1 and 1, with SNAinh =
0 at the steady state arterial pressure.
Figure 2.4: An illustration of baroreceptor reex resetting. Originally the baroreceptor
reex leads to sympathetic nerve activity according to the sigmoid relationship centered
at PA = 100 (solid line). After arterial pressure has been elevated to 130 mmHg and
sustained at that level, the curve shifts to the right (dashed line).
Chronic activation of the slow excitatory response can be modeled as a rst-order
delayed response to a simultaneous elevation of circulating plasma angiotensin II and
sodium:
exc
dSNAexc
dt
=   (1  1
1 + e5(x(t d) 3)
)  SNAexc (2.14)
with x(t   d) = [NaCl]P (t d) [NaCl]P;00:001  AngII(t d) AngII0AngII0 is a dimensionless quantity,
where exc is the time constant of the response, d = 5  24  60 minutes is the time
delay of the response [78],  is the sympathetic sensitivity to the stimulus; [NaCl]P is
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plasma osmolarity (see Section 2.4), and AngII is plasma angiotensin II (see Section
2.5). Figure 2.5 shows an example of the chronic SNA response.
Figure 2.5: Solution (slow activation of the sympathetic nerve activity, SNAexc) of (2.14)
in response to a sustained elevation of plasma osmolarity and AngII.
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2.4 The whole-body exchange module
2.4.1 Modeling objectives
The understanding of volume dynamics within the vascular space is incomplete without
a model of the whole-body transport of uid and solutes. Ingestion of extra water and
sodium upsets osmotic and hydrostatic balances with the interstitial uid and cells,
causing uid, solutes, and protein shifts in and out of the vascular space. Thus, a
mathematical model of whole-body uid, protein, and sodium chloride distribution is
needed. The following model is based on the published model of acute uid-solute
transport in the human body [43] with the following modications: solute exchange
with cellular compartments, the Donnan eect and and small ion osmotic pressures are
assumed to be insignicant; of all small ion solutes only sodium chloride dynamics is
represented; descriptions of lymphatic ow, interstitial pressure, protein transport rate,
and oncotic pressure are corrected; the parameters were tted or scaled to represent the
uid-solute dynamics in a rat.
2.4.2 Model formulation
Figure 2.6 shows the division of the body water, proteins, and sodium chloride content
across four major compartments connected either by a membrane or a lumen. The four
compartments are tissue cells (TC), interstitial uid (IF), plasma (P), and red blood
cells (RBC). The plasma compartment also exchanges the water and sodium chloride
with external compartments. Intake of water and sodium chloride is considered to be
through ingestion or infusion (I). Loss of water and sodium chloride is considered to be
through urinary excretion into the bladder (B) only and other losses such as through
perspiration are not considered. Each compartment is considered to be well mixed
with spatially constant descriptive parameters. Total protein content is assumed to be
constant at all times.
The transcapillary transport of uid from the plasma into the interstitium is driven
by the Starling law, which states that the bulk movement of uid across the capillary
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Figure 2.6: Schematic of exchange of three substances (V , water; Q, protein, and NaCl,
sodium chloride) between four body compartments: tissue cells (TC), interstitial uid
(IF), plasma (P), and red blood cells (RBC). Transport rate of a substance X from
compartment A to compartment B across a membrane is denoted as JX;A B (shown
as a black arrow) and via lymphatic vessels is denoted as bJX;A B (shown as a shaded
wide arrow). The only intake (I) of water and sodium chloride from an external source
is considered to be through the plasma compartment, as well as the only loss into the
bladder (B) via urinary excretion. Compartments are drawn to scale, with area roughly
proportional to volume. The process of urinary excretion (star) is discussed in detail in
Section 2.5.
membrane is proportional to the net sum of ltration driven by the transmembrane hy-
drostatic pressure gradient and reabsorption is driven by transmembrane oncotic pres-
sure gradient. The transport of proteins and sodium chloride is governed by diusive-
convective mechanisms. The substances are returned back into the circulation via the
lymphatics by convective mechanisms. It is assumed that only uid (no solute or pro-
tein) exchange happens across the cellular membranes, which are governed by osmotic
gradient.
Nearly 80% of total osmolarity of the interstitial uid and plasma and 10% of intra-
cellular space is produced by sodium and chloride ions. Transport of small ions other
than sodium and chloride is not of major signicance for the study of long-term blood
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pressure control. Thus the following assumptions are made to simplify the model: small
ion content of cells remains constant at all times and small ion content of interstitium
and plasma as well as its transport is proportional to that of the sodium chloride content.
Sodium chloride content balance equations
The sodium chloride content (NaCl) balances are:
dNaClIF
dt
= JNaCl,P-IF   bJNaCl,IF-P (2.15)
dNaClP
dt
= JNaCl,I-P   JNaCl,P-U   JNaCl,P-IF + bJNaCl,IF-P (2.16)
where the sodium chloride intake ow JNaCl,I-P is given and urinary excretion ow
JNaCl,P-U is the net sum of all distal nephron sodium chloride outows (see Section 2.5
for details):
JNaCl,P-U = Nn  JNaCl,DN (2.17)
The total small ion content (Osm) of extracellular compartments (plasma and in-
terstitium) is assumed to be proportional to their respective sodium chloride contents:
OsmP = 1:14 NaClP (2.18)
OsmIF = 1:14 NaClIF (2.19)
while the total small ion content of intracellular compartments (tissue cells and red
blood cells) has a dierent proportionality coecient and is constant at all times:
OsmTC = 24:17 NaClTC = Constant (2.20)
OsmRBC = 24:17 NaClRBC = Constant (2.21)
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Fluid mass balance equations
The uid mass balances are:
dVP
dt
= JV,I-P   JV,P-U + JV,RBC-P   JV,P-IF + bJV,IF-P (2.22)
dVIF
dt
= JV,P-IF + JV,TC-IF   bJV,IF-P (2.23)
dVTC
dt
=  JV,TC-IF (2.24)
dVRBC
dt
=  JV,RBC-P (2.25)
where the intake ow JV,I-P is given and urinary excretion ow JV,P-U is the net sum of
all distal nephron uid outows (see Section 2.5 for details):
JV,P-U = Nn  JV,DN (2.26)
The uid shift across the cellular membrane is driven by the osmotic gradient, and
the cellular water permeability is very high compared to other transport coecients.
Thus, the above system can be simplied by assuming that the water shift in and out of
cells is instantaneous, dropping dierential equations for VTC and VRBC, and adjusting
all volumes by the shift instantly, independent of the terms on the right hand side of
the above equations:
VRBC-P =
OsmP  VRBC  OsmRBC  VP
OsmRBC +OsmP
(2.27)
VTC-IF =
OsmIF  VTC  OsmTC  VIF
OsmTC +OsmIF
(2.28)
Protein content balance equations
A small portion of plasma proteins leaks across capillary membrane into the interstitial
space where it is collected by the lymphatic vessels and returned into the blood pool via
emptying into a large vein near the heart. Protein transport is an important contributor
to the model of uid transport as it creates oncotic gradient across the capillary mem-
brane. The dynamics of protein synthesis has not been fully characterized [8]. However,
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it has been observed that plasma protein remains constant despite various disturbances
due to water, solute or protein infusion.
The protein content (Q) balances are:
dQIF
dt
= JQ,P-IF   bJQ,IF-P (2.29)
QP +QIF = QT = Constant (2.30)
Transcapillary transport equations
Transcapillary uid ltration is driven by Starling forces due to hydrostatic and oncotic
gradient across the capillary membrane:
JV,P-IF = KC  (PC   PIF   Q  (C   IF)) (2.31)
where KC is the hydraulic permeability coecient; Q is the reection coecient for
proteins; PC and PIF are the hydrostatic pressures in the capillary and interstitium,
respectively; C and IF are the oncotic pressures in the capillary and interstitium,
respectively. Note, that the contribution of sodium chloride to the osmotic pressures is
omitted since the diusion happens quickly and does not aect capillary ltration in an
appreciable way. Capillary hydrostatic pressure is determined by the arterial perfusion
pressure and myogenic response of the arterioles to buer the pressure and calculated
via Circulatory Module (see Section 2.2).
Interstitial hydrostatic pressure PIF is a highly nonlinear function of the interstitial
volume VIF since the compliance of the interstitium varies signicantly with hydration
state. Interstitial pressure also varies from tissue to tissue, ranging from -5 mmHg
in subcutis to +6 mmHg in kidneys [1, 37]. No distinction among tissues is made in
the model, thus the interstitial pressure is presented phenomenologically, as an average
value across all major tissues, using experimental curves to derive the rate of change
around its normal value:
PIF = p1   p2
1 + ep3(VIF p4)
(2.32)
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The oncotic pressure (c), also referred to as colloid osmotic pressure, is expressed
as a second order polynomial of protein concentration cA ([24], expressed in grams per
liter):
C =
QP
VP
 (0:0029  QP
VP
+ 0:1631) (2.33)
IF =
QIF
VIF,Av
 (0:0029  QIF
VIF,Av
+ 0:1631) (2.34)
Note, that the protein concentration in the interstitial space is based on the avail-
able interstitial volume VIF,Av. The extracellular matrix behaves as a porous structure
with pores of about 20-25nm in diameter, due to the presence of a collagen structure
and negatively-charged hayluronan and proteglycans. This results in macromolecular
crowding of the interstitial space, excluding a portion of the total interstitial volume for
the protein diusion. The exclusion properties depend on the hydration state of the in-
terstitium. Based on data presented in [111], [43], and [5] we assume linear dependence
of the available interstitial volume on the total interstitial volume (VIF):
VIF,Av = p1 + p2  (VIF   VIF,0) (2.35)
Transcapillary solute ltration is dominated by diusive mechanism with the rate
of diusion is about 1000 times faster than that of convection:
JNaCl,P-IF = KNaCl  ([NaCl]P   [NaCl]IF) (2.36)
where KNaCl is the capillary permeability-surface area product for sodium chloride and
[NaCl]P and [NaCl]IF are the concentrations of sodium chloride in plasma and interstitial
uid, respectively:
[NaCl]P =
NaClP
VP
; [NaCl]IF =
NaClIF
VIF
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Transcapillary protein ltration has to take both diusion and convection mecha-
nisms into account as they are of relatively similar magnitude:
JQ,P-IF = (1  Q)  JV,P-IF  [Q]P +KQ  ([Q]P   [Q]IF) (2.37)
where KQ is the capillary permeability-surface area produce for protein and [Q]P and
[Q]IF are the concentrations of protein in plasma and interstitial uid, respectively:
[Q]P =
QP
VP
; [Q]IF =
QIF
VIF
Lymphatic transport equations
The lymphatic return of water is often described phenomenologically as a piecewise-
linear function of interstitial pressure ([15, 26, 43]), since the mechanisms by which
lymph vessels collect and propel uid have not been studied extensively. We model
lymphatic ow as a logistic function, using the experimental data reported in [87] and
[9]: bJV,IF-P = p1   p1
1 + ep2(PIF p3)
(2.38)
The lymphatic return of protein and sodium chloride is dominated by convection:
bJQ,IF-P = bJV,IF-P  [Q]IF (2.39)bJNaCl,IF-P = bJV,IF-P  [NaCl]IF (2.40)
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2.5 The renal and hormonal module
2.5.1 Modeling objectives
The whole-body model of pressure and volume control requires that a dietary change of
water or sodium intakes lead to matching renal excretion of water and sodium. Accord-
ing to AngII-salt experimental data, such renal response occurs under various conditions
of renal perfusion pressure and circulating angiotensin II. Thus, the mathematical model
of renal function is required to meet at least the following conditions:
1. It represents major renal anatomical features and physiological phenomena of
ltration, reabsorption, and hormonal response in a normal, resting, conscious
rat.
2. Renal excretion of water and sodium matches dietary intake (normal physiological
range) within several days.
3. Accumulated or lost water and sodium are in agreement with experimentally ob-
served values.
4. Renal perfusion pressure and renal venous pressure have little to no eect on renal
excretion.
5. Externally xed level of circulating angiotensin II does not prevent proper renal
response to dietary changes.
2.5.2 Literature review
Mathematical models of renal function can be classied into three categories by the
level of detail in representation of renal physiology. Models with a high level of detail
represent specic vascular and tubular structure and function in vast detail but focus on
a specic aspect of renal physiology rather than the entire phenomenon of sodium and
water excretion. There are models for studying renal autoregulation response [4, 66],
glomerular ltration [50], nephron interaction [65], transport properties of a portion of
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a tubule [109], medullary concentration [64], and so on. The eort of combining results
of these models into one is still ongoing [102].
Low-level-of-detail models ignore most of the structural and functional properties
and represent excretion phenomenologically [41, 51, 101]. The limitation of these models
lies with oversimplifying controlling factors which are either too limiting (e.g. renal
excretion is driven by arterial pressure [39]) or not detailed enough (e.g. renal excretion
is assumed to be driven by sodium intake directly [6]).
The third category is comprised of models which represent some physiological and
structural detail but with signicant simplication of both renal anatomy and regulatory
mechanisms, in order to maintain the ability to simulate overall regulation of water and
sodium excretion. These models are usually built on a lumped-nephron representation
of tubular anatomy but vary greatly in the amount of attention paid to glomerular ltra-
tion control, number of representative nephrons, medullary interstitium, reabsorption
control, hormonal regulatory eects, etc. For the purposes of the modeling objectives
presented here, a mid-level-of-detail model is deemed appropriate. There are several
published models of renal function of mid-level detail [47, 56, 55, 72]. However, all three
models are based on the assumption that arterial pressure strongly inuences glomerular
ltration and/or tubular reabsorption which directly contradicts the modeling objective
#4.
A signicant modeling challenge is determining how to interface the renal model
with the extra-renal ones, especially the circulatory and uid-solute shift models. Kid-
neys sense sodium and water intake indirectly, via changes in the extra-renal responses
to dietary inputs (e.g. hydrostatic and osmotic pressures, plasma composition, and
hormonal input) and at the same time kidneys modify those responses by varying total
body sodium and water. This complex interaction seems to be the main reason why
many renal models are standalone [72, 102]. For all other models, without exception, the
problem has been addressed by assuming that the arterial pressure is the sole controller
of glomerular ltration and/or tubular reabsorption [40, 47, 51, 55]. This assumption,
however, limits the utility of the model for two reasons, 1) because it contradicts ex-
perimental studies which show that renal excretion can be varied without changes in
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arterial pressure ([10, 86]) and 2) because it asserts an exclusive mechanistic link be-
tween sodium intake and arterial pressure. Mathematical models relying on such a link
are not suitable for the investigation of non-renal causes of hypertension.
A novel model of renal excretion is presented in the following sections. When com-
bined with the circulatory and uid-solute shift models, it produces a correct response
to various dietary change in sodium and water intakes under both naturally varying and
clamped angiotensin II. The model does not rely on perfusion pressure for modulation
of sodium excretion. Two features of the model, the ability to match excretion despite
changes in arterial pressure or angiotensin II, make it a novel contribution to the eld.
2.5.3 Model formulation
Figure 2.7 shows the division of the renal excretory function into three subsystems: the
vascular, tubular, and hormonal subsystems. It also shows the main internal subsystem
variables and external control variables: renal arterial and venous pressures, hematocrit3
, plasma osmolarity4 , and plasma protein concentration5 . The kidneys are modeled
as a set of 60,000 identical ltering units, each one is represented by a nephro-vascular
module composed of a glomerulus with aerent and eerent arterioles and a renal tubule.
Aerent and eerent arterioles are modeled as cylindrical tubes. Both arteriolar
resistances are functions of local hematocrit and vessel diameter (Figure 2.8). The size
of the aerent arteriole is driven by the myogenic response to perfusion pressure and
angiotensin II. The size of the eerent arteriole is under control of angiotensin II. The
glomerular ltration rate is determined by the gradient of hydrostatic and oncotic6
pressures across glomerular capillary membrane and a ltration coecient (Figure 2.9).
The tubular system consists of four segments representing proximal tubule, descend-
ing limb of Henle, ascending limb of Henle, and distal nephron which combines distal
tubule and collecting duct combined (Figure 2.10). Fluid and sodium reabsorption in
3 Hematocrit is the ratio of the volume of red blood cells to the total volume of blood.
4 Plasma osmolarity is a measure of the body's electrolyte-water balance, expressed in number of
osmoles of solute per liter of solution (Osm/L).
5 Plasma protein concentration, measured in grams per liter, is the major determinant of the osmotic
pressure.
6 Oncotic pressure is the osmotic pressure exerted by blood proteins.
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each segment is governed by various physical and hormonal controls. In particular, the
proximal tubule isotonic reabsorption is determined by the gradient of hydrostatic and
oncotic pressures across the peritubular capillary membrane, rather than specic trans-
port across the tubular wall. The reabsorption of water is varied by vasopressin eects
on the distal nephron. The reabsorption of sodium is modulated by angiotensin II eect
on the ascending limb of Henle and eects of aldosterone and atrial natriuretic peptide
on the distal tubule. Tubuloglomerular feedback and the eect of renal sympathetic ac-
tivity are not included in the model since neither is critical to sodium excretion control.
Other substances such as potassium, glucose, urea, etc are assumed to be in constant
balance.
The hormonal response of the system consists of vasopressin, angiotensin II, aldos-
terone, and atrial natriuretic peptide (ANP). Vasopressin is assumed to be controlled
by plasma osmolality, ANP release is stimulated by angiotensin II and venous pressure,
angiotensin II concentration varies in response to sodium ow senses by the macula
densa, and aldosterone response is driven by angiotensin II for low to moderate levels
of angiotensin II and by ANP for high values of angiotensin II. Medullary interstitium
is not explicitly represented but reabsorption due to changes in medullary osmolality
gradient is incorporated via overall vasopressin's eects on the distal nephron.
Time-dependent processes in the glomerular capillaries and nephron tubules are
very rapid (several seconds) compared to hormonal regulation and dynamics of other
modules. Thus, the glomerular and tubular subsystems are assumed to be in a quasi
steady-state with respect to the rest of the system. Hormonal dynamics is described
via ordinary dierential equations. Each subsystem is modeled in the simplest manner
possible while reecting the most important characteristics of uid and sodium transport
in the kidney. For a detailed description of renal physiology refer to Appendix A.
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Figure 2.7: Structure of the renal module. The module is comprised of three subsystems:
vascular, tubular, and hormonal subsystems. In each subsystem internal variables are
highlighted in white and outputs are highlighted in grey. Inputs from other modules
are highlighted by thick outlines. Renal module outputs that inuence other modules
are highlighted in grey with thick outlines. Some of the complex internal dependencies
(e.g. those for the glomerular pressure) are omitted and their outputs are shown in
hexagon shapes. Excitatory connections are shown by solid-ended arrows and inhibitory
connections are shown by at-ended arrows.
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Glomerular ltration
Blood, composed of plasma, proteins and red blood cells, is delivered via an aerent
arteriole to a glomerulus. A portion of the protein-free uid is ltered into the Bowman's
capsule of the nephron and the rest of the blood ows through the eerent arteriole to
the peritubular capillaries where it merges with the uid and solutes reabsorbed from
the nephron and then ows into systemic veins.
The model structure of glomerulus is shown in Figure 2.8.
Figure 2.8: Model of renal corpuscle.
In this section the following inputs are assumed to be known: arterial pressure (PA),
venous pressure (PV ), proximal tubule pressure (PPT), peritubular capillary pressure
(PR), aerent hematocrit (HA), aerent plasma protein concentration ([Q]A), aerent
arteriolar resistance (RA), eerent arteriolar resistance (RE), and glomerular ltration
coecient (KG). Using these inputs the following expressions are derived: aerent ar-
teriolar blood ow (BFA), eerent arteriolar blood ow (BFE), eerent plasma protein
concentration ([Q]E), eerent hematocrit (HE), glomerular pressure (PG), and glomeru-
lar ltration rate (GFR).
Blood ow across the aerent arteriole, BFA, is determined by the dierence between
arterial pressure PA and glomerular pressure PG and aerent arteriolar resistance RA:
BFA =
PA   PG
RA
(2.41)
Note, that the sum of all individual blood ows gives the total renal blood ow (RBF)
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Figure 2.9: Example of transcapillary pressures (P , hydrostatic; , oncotic) along the
glomerular and peritubular capillaries in the rat kidney. Filtration equilibrium is often
reached before the end of the glomerular capillary. Rapid fall of hydrostatic pressure
between the capillaries is due to eerent arteriolar resistance.
used in the Circulatory Module (same as equation (2.9)): RBF = BFA Nn:
Blood ows across the eerent arteriole BFE and the renal venule BFV are:
BFE =
PG   PR
RE
(2.42)
BFV =
PR   PV
RV
(2.43)
where PR is peritubular capillary pressure, PV is renal venous pressure, RE is the eerent
arteriolar resistance and RV is the resistance of peritubular capillaries.
Note that BFV does not account for all of the renal venous blood ow as it only
includes eerent blood ow and the proximal reabsorption rate. The third component
is the tubular reabsorption from the descending limb of Henle and distal nephron (see
the section below) which is returned via vasa recta, not explicitly represented in this
renal model but is accounted for in the circulatory model (Section 2.2, Figure 2.1). The
total renal venous blood ow can be also expressed as BFA JV,DN, where JV,DN is the
urinary water excretion rate.
Protein and red blood cells are not ltered into the nephron and thus their aerent
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and eerent ows are equal:
BFA  (1 HA)  [Q]A = BFE  (1 HE)  [Q]E (2.44)
BFA HA = BFE HE (2.45)
where [Q]A and [Q]E are protein concentration at the aerent and eerent arteriole,
respectively; HA and HE are the aerent and eerent hematocrit, respectively. The
aerent hematocrit is the same as the arterial hematocrit and is computed as a ratio of
red blood cell volume (VRBC) to the sum of red blood cell and plasmas (VP ) volumes
(i.e. the total blood volume VB):
HA =
VRBC
VP + VRBC
=
VRBC
VB
(2.46)
Similarly, the aerent protein concentration is the same as the plasma protein concen-
tration: [Q]A = [Q]P .
By the conservation of mass, the single nephron glomerular ltration rate (GFR) is
the dierence between ows:
GFR = BFA   BFE (2.47)
Glomerular ltration along the glomerular capillaries is governed by the gradient
of hydrostatic pressures in the glomerulus and the Bowman capsule of the nephron
along with oncotic pressure in the glomerular capillary. As the blood ows through the
glomerular capillaries, water is ltered into the nephron and thus the protein concentra-
tion rises, reducing pressure gradient needed for ltration (see Figure 2.9 and detailed
description for Figure A.4 in Appendix A).
To model glomerular ltration, a spatially-distributed model is used as described
in [24]. The glomerular capillary bed is presented as a permeable tube of xed length,
radius and permeability. The equation for volumetric ow rate of plasma (F ) within
the glomerular capillaries can be derived using conservation of mass:
dF
dx
=  KG  (PG   PPT   (c)); F (0) = BFA  (1 HA) (2.48)
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where x is the dimensionless distance along the glomerular capillary so that F (1) =
BFE  (1 HE); c is protein concentration, KG is ltration coecient of the glomerular
membrane, PG is the hydrostatic glomerular pressure, PPT is the hydrostatic Bowman's
pressure (assumed to be the same as proximal tubule pressure), and  is the oncotic
pressure. The protein concentration can be calculated using conservation of protein
equation (2.44):
c(x) =
[Q]A  BFA  (1 HA)
F (x)
There is no signicant change in PG along the length of the capillary, although the
assumption of a small gradient allows for a more precise model of ltration equilibrium
often observed in rat experiments [24]. Such precision is not necessary for the purposes
of the renal excretion model here, thus PG is assumed to be spatially constant.
The oncotic pressure (c) is expressed as a second order polynomial (per [24], also
used in Section 2.4):
(c) = c  (0:0029  c+ 0:1631) (2.49)
where c is protein concentration, expressed in grams per liter.
Bowman's pressure is assumed constant since GFR is tightly controlled and the
ltration is dominated by oncotic pressure gradient.
The model of glomerular ltration described by equations (2.41)-(2.49) can be solved
by an iterative method, using Matlab's fzero function. An initial guess for PG is made
and the model is solved without invoking (2.42) which is used as the exit condition.
Tubular reabsorption
As the ltrate of water and solutes ows through the renal tubule it undergoes a sequen-
tial and selective reabsorption before exiting into the bladder. The model structure of
renal tubule is shown in Figure 2.10. For detailed description of renal tubule anatomy
and reabsorption processes see Appendix A.
The tubule is assumed to be rigid and divided into four consecutive compartments
representing proximal tubule (PT), descending limb of Henle (DL), ascending limb of
Henle (AL), and distal nephron (DN) consisting of distal tubule and collecting ducts.
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Figure 2.10: Structure of renal tubule and reabsorption process. Luminal ows through
the tubule are shown by thick grey arrows. The fraction of luminal ow reabsorbed
back into circulation is shown by thin black arrows.
In each compartment a fraction of water inow () and/or a fraction of sodium chloride
inow () is removed. The water outow from a compartment X is denoted as JV;X
and the sodium chloride outow as JNaCl,X.
Glomerular ltration into the proximal tubule and the reabsorption from the proxi-
mal tubule into the peritubular capillaries is isoosmotic with plasma. Thus the luminal
ows of water and sodium chloride from the proximal tubule into the descending limb
of Henle are:
JV,PT = (1  PT) GFR (2.50)
JNaCl,PT = (1  PT) GFR  [NaCl]P (2.51)
where [NaCl]P is plasma sodium chloride concentration and
PT = PT (2.52)
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In the descending limb of Henle only water is reabsorbed, thus the water and sodium
chloride outows into the ascending limb of Henle are:
JV,DL = (1  DL)  (1  PT) GFR (2.53)
JNaCl,DL = JNaCl,PT (2.54)
In the ascending limb of Henle only sodium chloride is reabsorbed, thus the outows
are:
JV,AL = JV,DL (2.55)
JNaCl,AL = (1  AL)  (1  PT) GFR  [NaCl]P (2.56)
In the distal nephron both sodium and water are reabsorbed before the ltrate enters
the bladder. Thus renal excretion of water and sodium chloride are:
JV,DN = (1  DN)  (1  DL)  (1  PT) GFR (2.57)
JNaCl,DN = (1  DN)  (1  AL)  (1  PT) GFR  [NaCl]P (2.58)
Note, that the sum of all individual renal excretion uid ows gives the total renal
excretion of volume used in the Circulatory Module and Whole-Body Exchange Module
(equations (2.10) and (2.26)):
JV;P U = JV;DN Nn:
Similarly, the total sodium excretion used in the Whole-Body Exchange Module is the
net sum of all individual nephron sodium excretion ows (equation (2.17)):
JNaCl,P-U = JNaCl,DN Nn
Models for each of the tubular reabsorption coecients are presented below. For
detailed description of physiology see Appendix A.
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Most models of proximal reabsorption are based on the transport across the renal
tubule, rather than the uptake by the peritubular capillaries. However, proximal re-
absorption is dominated by the physical forces similar to those governing glomerular
ltration (see Figure 2.9). The forces favor movement of the isoosmotic uid from the
proximal tubule into the peritubular capillaries. A model based on the physical force
description has been shown to agree with the experimental data [25]. Moreover, it al-
lows an elegant explanation of glomerulotubular balance and the changes in its eciency
under varying inputs.
Similarly to (2.48), the volumetric ow of plasma (F ) through peritubular capillaries
is described as:
dF
dx
=  KR  (PR   PR,IF + R,IF   (c(x))); F (0) = BFE  (1 HE) (2.59)
where x is the dimensionless distance along the capillary, KRR is the reabsorption coef-
cient, PR is the peritubular capillary pressure, PR,IF is the renal interstitial pressure,
and R,IF is the renal interstitium osmotic pressure. Renal interstitial pressures PR,IF
and R,IF are assumed constant. Protein concentration c(x) can be calculated using
conservation of protein mass:
c(x) =
[Q]E  BFE  (1 HE)
F (x)
(2.60)
The proximal tubule reabsorption rate is then computed as the dierence of per-
itubular plasma outow and eerent arteriolar plasma ow so that the reabsorption
coecient for the proximal tubule is a ratio of the reabsorption rate to glomerular
ltration rate:
PT = PT =
F (1)  F (0)
GFR
(2.61)
Water reabsorption in the descending limb of Henle is due to water permeable tubu-
lar walls and osmotic concentration gradient of the medulla. Although the medullary
osmolality varies the reabsorption in the descending limb is limited by the constant
tubular permeability. Thus, DL is assumed constant.
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Water reabsorption in the distal nephron is strongly dependent on varying permeabil-
ity driven by vasopressin concentration. Vasopressin inserts aquaporin channels in the
tubular membrane of collecting ducts, thus increasing water reabsorption and medullary
osmolality gradient. Since the concentrating mechanism of mammalian medulla is not
well-understood [64], the distal water reabsorption is modeled as a function of vaso-
pressin concentration ([AVP]P ) which indirectly incorporates both eects:
DN = p1 + p2  [AVP]p3P (2.62)
Sodium reabsorption in the ascending limb is inhibited by angiotensin II concentra-
tion (AngII):
AL = p1   p2
1 + ep3(AngII p4)
(2.63)
Sodium reabsorption in the distal nephron is driven by aldosterone (Ald), which
regulates the number of sodium channels in the tubular membrane:
DN = p1   p1
1 + ep2(AVP p3)
(2.64)
Regulation of arteriolar resistances
The expression for the resistance R of an arteriole is based on Poiseuille's law:
R =
8l
r4
where  is blood viscosity, l is the arteriolar length, and r is the arteriolar radius.
At low vessel diameter, blood viscosity becomes strongly dependent on the hemat-
ocrit of the local blood ow, known as a Fahraeus-Lindqvist eect [83]. The phenomenon
is called relative apparent blood viscosity. Since aerent arteriolar diameter is about 15
m and eerent arteriolar diameter is about 12 m, and these diameters are aected by
various controls, the hematocrit eect cannot be ignored. Thus, the aerent arteriolar
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resistance (RA) and the eerent arteriolar resistance (RE) are modeled as:
RA = RA;b  (HA; dA)
(0; dA;0)
 d
4
A;0
d4A
(2.65)
where dA is the aerent arteriolar diameter, HA is the hematocrit of the aerent blood
ow, and RA;b is the aerent resistance at basal diameter dA;0 and zero hematocrit.
Similarly, the expression for the eerent arteriolar resistance (RE) is:
RE = RE;b  (HE ; dE)
(0; dE;0)
 d
4
E;0
d4E
(2.66)
where dE is the eerent arteriolar diameter, HE is the hematocrit of the eerent blood
ow, and RE;b is the eerent resistance at basal diameter dE;0 and zero hematocrit.
An empirical equation for the variation of relative apparent blood viscosity  was
derived by [83] based on the comprehensive analysis of extensive experimental data:
 =
"
1 + (   1)  (1 H)
C   1
(1  0:45)C   1 

D
D   1:1
2#


D
D   1:1
2
(2.67)
with
C =
 
0:8 + e 0:075D
   1 + 1
1 + 10 11D12

+
1
1 + 10 11D12
and
 = 220  e 1:3D + 3:2  2:44  e 0:06D0:645
where D = 0:84d with d being the vessel diameter expressed in microns. The coecient
of 0.84 is required to make an adjustment for the rodent model, since mean corpuscular
volume of rodent blood cells is smaller than that of human red blood cells, for which
the above formulas were derived.
The aerent vascular diameter is controlled by a myogenic response to an increased
arterial pressure and angiotensin II while the eerent vascular diameter is passively
increased by distending pressure and reduced by angiotensin II:
dA = dA;0 + p1  (PA   PA;0) + p2  (AngII AngII0) (2.68)
63
dE = dE;0 + p1  (PG   PG;0) + p2  (AngII AngII0) (2.69)
where both diameters are expressed in microns and parameters are chosen based on
general directional and relative change experimental observations [14]. The eect of
AngII on the eerent arteriolar diameters ceases below normal values of AngII.
After the uid is reabsorbed into peritubular capillaries it is carried back into the
veins. The resistance of the peritubular capillaries is modulated by AngII [53]. We do
not model individual resistances of peritubular capillaries RV per nephron and instead
represent the total renal venous resistance RVR to the ow:
RVR = Nn RV = p1 + p2  (AngII AngII0) (2.70)
where the eect of AngII ceases below normal values of AngII.
Hormone response
The hormone concentrations included in this model are: angiotensin II, aldosterone,
atrial natriuretic peptide, and vasopressin. All four hormones exert control on renal
reabsorption processes as discussed above. The following section describes the control
of hormone response in the model. A detailed description of the physiology can be found
in Appendix A.
In general, plasma hormone concentration (X) can be described by the rates of the
hormone secretion (MX) and clearance which is proportional to the hormone concen-
tration and has a known half-life constant (hX):
dX
dt
= fMX   ln 2
hX
X
where the rate of secretion is a function of one or more control factors so that fMX =
ln 2
hX
X0 when all controls are quiescent. However, experimental measurements of the
hormone concentration, not the rate of secretion are usually available and thus the
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following form for expressing hormone concentration dynamics is used:
dX
dt
=
ln 2
hX
 (MX  X)
where MX = X0 when all control of secretion are quiescent.
Plasma angiotensin II concentration is determined by the renin production by the
juxtaglomerullar cells in response to an increased sodium chloride ow at macula densa
JNaCl,AL and is inhibited by own concentration:
dAngII
dt
=
ln 2
hAngII
 (MAngII  AngII) (2.71)
where
RAngII = JAngII,I-P + (p1   p1
1 + ep2(x p3)
)  (1  1
1 + ep4 [AngII]P
) (2.72)
where JAngII,I-P is the infusion rate of exogenous angiotensin II and x = JNaCl,AL Nn.
Atrial natriuretic peptide, or ANP, is a hormone secreted by cardiac muscle cells in
response to angiotensin II and elevated venous pressure PV , among other stimuli [54]:
dANP
dt
=
ln 2
hANP
 (MANP  ANP) (2.73)
where
MANP = p1   p2
1 + ep3(AngII p4)
+ p5  PV (2.74)
Plasma aldosterone concentration (Ald) is proportional to the concentration of an-
giotensin II for low to moderate values of angiotensin II (AngII). At high levels of
angiotensin II (about twice the normal value) and especially in the presence of elevated
plasma osmolality aldosterone production dissociates from angiotensin II [62]. The
mechanism behind this dissociation is not well studied. At high levels of angiotensin II
production of aldosterone may be inhibited by elevated plasma osmolality [70] or atrial
natriuretic peptide [16]. The physiological eect of the hormones on the distal nephron
is delayed by 1-2 hours as changes in gene expression and protein synthesis need to take
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place in order to insert active sodium transport channels into the tubular membrane.
This delay is included into the time constant of the hormone dynamics:
dAld
dt
=
ln 2
hAld
 (MAld  Ald) (2.75)
where
MAld = (p1   p2 ANP)  (p3   p3
1 + ep4(AngII p5)
) (2.76)
Vasopressin, also known as arginine vasopressin (AVP), is released in response to
increased plasma osmolality ([NaCl]P ) and the responsiveness is sensitized by the cir-
culating angiotensin II [13]:
dAVP
dt
=
ln 2
hAVP
 (MAVP  AVP) (2.77)
where
MAVP = p1 AngII  ([NaCl]P   [NaCl]P;0) + AVP0 (2.78)
truncated at 0, with the slope of the response derived from the data presented in [88]
and truncated at 1 when angiotensin II is below its normal value.
Chapter 3
Analysis
The objective of this chapter is to demonstrate the validity of the model and to analyze
its steady-state behavior. We are particularly interested in elucidating the causal factors
behind pressure-natriuresis phenomenon in the model. We show that the multifactorial
control of arterial pressure necessitates a multidimensional view of all of the control
mechanisms, renal and non-renal. Pressure-natriuresis curves are the lower-dimension
observations and reect a mix of controls within the system, rather than simply renal
control. To establish our argument, we structure the chapter in the following way:
1. The reduction technique using time scale separation is applied to the model. It
separates out its fast and slow dynamics. The fast subsystem represents all major
established physiological controls in the model and is responsible for the early
onset phase of hypertension (see Figure 1.4). The slow subsystem consists of the
hypothetical slow activation of the sympathetic nervous system and is responsible
for the maintenance phase of hypertension.
2. The steady state response of the fast subsystem is validated by comparing its
predictions to the available experimental data in three scenarios, where either
plasma AngII levels, sodium intake, or both AngII and sodium are elevated.
3. A global sensitivity analysis demonstrates a multifactorial nature of blood pressure
control and identies some of the key factors which can aect steady state of
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arterial pressure in the fast subsystem.
4. The steady state response of the complete system is approximated by the reduced
(degenerate) system. Two of the key factors from the global sensitivity analysis,
the unstressed volume and extra-renal arteriolar diameter, are assumed to be
the variables of this subsystem, driven by the slow sympathetic activation. This
allows an explanation of the maintenance phase of AngII-salt hypertension which
is validated against experimental observations.
5. The long-term response of arterial pressure to varying salt intake levels generates a
surface in a three-dimensional space, with axes of renal and sympathetic control.
The projections of this surface generate the curves of the pressure-natriuresis
phenomenon which reect a combination of the two controls.
All simulations were performed in Matlab. The results of the analysis will be dis-
cussed in Chapter 4.
3.1 Time scale separation
All of the dynamic equations of the model have time scale of minutes to hours, except
for the hypothetical latent activation dynamics, which is assumed to act on the scale of
days to weeks. This suggests that the analysis of the model can be simplied via singular
perturbation theory. In particular, we will use the outer solution to approximate the
slow manifold in the discussion of the eects of the slow activation of the sympathetic
nervous system and generation of the pressure-natriuresis curves.
We rst express the entire system as:
dy
dt
= f(y; z; t); y(0) = y0 (3.1)

dz
dt
= g(y; z; t); z(0) = z0 (3.2)
where 0 <   1, t is the time variable of the slow phenomena, y is a vector of two
slow variables, the unstressed blood volume (VUnstr) and extra-renal arteriolar diameter
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(dAS), and z is a vector of all remaining variables of the system (fast variables), in
particular, arterial pressure PA.
The system has to be nondimensionalized and rescaled in order to express . We
have done such derivation only for a simplied system shown in Appendix C and believe
this could be expanded in a straightforward way to the rest of the system. However,
this remains to be veried.
The system (3.1) is:
CA  dPA
dt
= CO  PA   PC
RAS
  RBF
CS  dPS
dt
=
PC   PS
RCS
  PS   PV
RV S
CV  dPV
dt
=
PS   PV
RV S
+ bJV,IF-P + JV;I P +RBF  JV;P U   CO
dNaClIF
dt
= JNaCl,P-IF   bJNaCl,IF-P
dNaClT
dt
= JNaCl,I-P   JNaCl,P-U
dVT
dt
= JV,I-P   JV,P-U
dVP
dt
= JV,I-P   JV,P-U + JV,RBC-P   JV,P-IF + bJV,IF-P
dQP
dt
= bJQ,IF-P   JQ,P-IF
dAngII
dt
=
ln 2
hAngII
 (RAngII  AngII)
dANP
dt
=
ln 2
hANP
 (RANP  ANP)
dAld
dt
=
ln 2
hAld
 (RAld  Ald)
dAVP
dt
=
ln 2
hAVP
 (RAVP  AVP)
dy
dt
=
PA   (y + x)
10
dx
dt
=
PA   x
240
with supporting algebraic equations as described in Chapter 2.
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The system (3.2) is:
exc
dSNAexc
dt
=   (1  1
1 + e5(x(t d) 3)
)  SNAexc
where x(t  d) = [NaCl]P (t d) [NaCl]P;00:001  AngII(t d) AngII0AngII0 with
dAS = p1   p2
1 + ep3(AngII p4)
  p5  (SNAexc   SNAinh)
and
VUnstr = VUnstr;0   p1  (SNAexc   SNAinh)
as described in Chapter 2.
The outer solution is obtained via the degenerate system by taking the limit of
(3.1)-(3.2) as ! 0:
dys
dt
= f(ys; zs; t); ys(0) = y0 (3.3)
0 = g(ys; zs; t) (3.4)
This system is referred to as the slow subsystem in the following sections.
The inner solution is obtained via the adjoined system. We rewrite (3.1)-(3.2) in
the fast time scale 
dy
d
= f(y; z; )
!0) dy
d
= 0 (3.5)
dz
d
= g(y; z; )
!0) dzf
d
= g(y; z; 0); (3.6)
This system is referred to as the fast subsystem in the following sections.
The inner solution is an approximation of the exact solution within a neighborhood
(boundary layer) of the initial condition. In our case the inner solution coincides with the
exact solution during rst 5 days of the simulation since the activation of the sympathetic
system is assumed to be delayed by 5 days. The match between the inner and the outer
solutions in the region where their time scales overlap has to be veried. In the simpler
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case we have shown that the adjoined system has a single stable root and thus the
quasi-steady states approximate the steady states of the original system. Since for the
full system we do not have the explicit solutions and since our practical focus lies with
the long-term behavior we will focus on the outer solution.
3.2 The onset phase of hypertension
The response of the fast subsystem to changes in AngII and sodium intake is of central
importance to the analysis of the model's long term behavior. The available experimen-
tal data falls into three categories: plasma AngII levels are modied without changes to
sodium intake, sodium intake is modied while AngII is controlled by normal physiolog-
ical mechanisms, or both plasma AngII and sodium are elevated. In the latter scenario,
a latent activation of slow mechanisms (such as the sympathetic activation) can be be
involved, thus only the data from the rst few days of the response (the onset phase)
can be used for the validation of the fast subsystem. The latent response has not be
shown to occur in the other two scenarios.
To represent typical experimental conditions, the following three input scenarios to
the system were simulated and validated: "High AngII + Normal Salt", "Normal AngII
+ High Salt", and "High AngII + High Salt", where "High AngII" means an infusion
of AngII is administered so that plasma AngII is elevated two-fold, "Normal AngII"
means plasma AngII is regulated by normal physiological processes, and "High Salt"
means that sodium intake is increased 5-fold from normal salt intake.
Since the experimental studies typically report measurements after an initial sta-
bilization period, only the steady states of the fast subsystem are validated. This is
deemed acceptable given the overall focus of the model on the long-term blood pressure
control. The experimental data were scaled to match the initial steady-state values of
the corresponding simulation to compare the relative changes in the responses.
The main simulation results are combined into a hemodynamic prole panel; i.e. the
responses of arterial pressure, cardiac output, total blood pressure and total peripheral
resistance to changes in plasma AngII and/or sodium intake. One panel per each of the
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three simulations is created. More detailed simulation results are provided in Section
3.2.4 in an additional three plots per each scenario. These simulation panels contain key
variables of each of the three system modules: the Circulatory Module panel, the Whole-
Body Exchange Module, and the Renal-Hormonal Module. All results are presented on
the same scale to allow quick comparison across scenarios. Normal steady-state (i.e.
values under "Normal AngII + Normal Salt") is shown as a dotted line on each plot
and relative change of the new steady state as a percentage of normal is shown on Day
6 for ease of data interpretation.
3.2.1 High AngII, normal salt intake
Consider the scenario "High AngII + Normal Salt", when sodium intake is normal, but
AngII infusion is administered starting on Day 2 so that the plasma AngII is elevated
two-fold within several hours. The hemodynamic prole of the system's response is
shown in Figure 3.1, left panel. More detailed results can be found in Section 3.2.4,
Figures 3.4, 3.5, and 3.6.
Table 3.1 shows that the model predictions are in good agreement with the experi-
mental data collected from several studies. There is a considerable variation in cardiac
output values reported in dierent studies, but it appears that the model predicts lower
than expected cardiac output response. Blood volume is also somewhat lower than
observed experimentally but within the experimental measurement error of 10%.
3.2.2 Normal AngII, high salt intake
Consider the scenario "Normal AngII + High Salt", when sodium intake is increased 5-
fold either by a change in salt diet or infusion, but AngII is under normal physiological
control. The hemodynamic prole of the system's response is shown in Figure 3.1,
middle panel. More detailed results can be found in Section 3.2.4, Figures 3.7, 3.8, and
3.9.
Table 3.2 shows that model predictions are in good agreement with the experimental
data collected from several studies. The behavior of arterial pressure in our model is
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Figure 3.1: Simulated hemodynamic proles of three scenarios: "High AngII + Normal
Salt" (left panel), "Normal AngII + High Salt" (middle panel), "High AngII + High
Salt" (right panel). Simulated response is shown in black; sodium input on the top plots
is shown in light grey; relative change on Day 7 as compared to the normal steady state
(dashed line) is shown as a percentage of normal.
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Variable Model [57] [67] [73] [27] [62] [45] [11]
MAP 1.14 1.2 1.2 1.21 1.15 1.05 1.08
CO 0.83 0.9 1.11
TPR 1.38 1.4 1.44 1
[NaCl]P 1 0.98 0.99
VB 0.95 1
GFR 0.94 0.99 0.92 1.05 1
RBF 0.64 0.65 0.68 0.68 0.95
Ald 1.56 1.45
ANP 1.67 1.88
Table 3.1: "High AngII + Normal Salt" scenario: Comparison between model pre-
dictions and available experimental data from various studies. Relative changes as a
fraction of control conditions of each study are shown. PA, mean arterial pressure;
CO, cardiac output; TPR, total peripheral resistance; [NaCl]P , plasma osmolarity; VB,
blood volume; GFR, glomerular ltration rate; RBF, renal blood ow; Ald, plasma
aldosterone concentration; ANP, plasma atrial natriuretic peptide concentration.
similar to the one observed in the model by Karaaslan et al. [55] which integrates simple
circulatory and renal functions, but is based on the premise of the GC theory in the
manner renal function is controlled. In both models arterial blood pressure rises to a
steady state quickly (within a day) with a slight overshoot.
3.2.3 High AngII, high salt intake
Consider the scenario "High AngII + High Salt", when the animal began receiving
AngII infusion to elevate plasma AngII levels about 2-fold, after already being on a
high sodium intake (5 times normal) for several days prior to the infusion. As discussed
at length in Chapter 1, this is the scenario of AngII-salt hypertension, where the animal
is expected to develop hypertension at a later stage. The acute response to this protocol
representing the onset phase of the hypertension only is shown in Figure 3.1, right panel.
More detailed results can be found in Section 3.2.4 (Figures 3.10, 3.11, 3.12, 3.13, 3.14,
and 3.15).
The results of the simulations can be validated against two experimental studies
discussed in Chapter 1: the study by Osborn and Fink [76] in rats (only arterial pressure
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Variable Model [57] [62] [45] [11] [108]
MAP 1.04 1 1 1 1.04 1.02
CO 1.11 1.1 1.09
TPR 0.93 0.9 0.81
[NaCl]P 1.02 1.02 1.02 1.05
VB 1.05 1 1
GFR 1.16 1.1 1.13
RBF 1.15 1.1
AngII 0.68 0.6
Ald 0.18 0.2 0.1
ANP 1.03 1
Table 3.2: "Normal AngII + High Salt" scenario: Comparison between model pre-
dictions and available experimental data from various studies. Relative changes from
normal condition (control) are shown. PA, mean arterial pressure; CO, cardiac out-
put; TPR, total peripheral resistance; [NaCl]P , plasma osmolarity; VB, blood volume;
GFR, glomerular ltration rate; RBF, renal blood ow; AngII, plasma angiotensin II
concentration; Ald, plasma aldosterone concentration; ANP, plasma atrial natriuretic
peptide.
was measured) and the study by Krieger et al [62] in canines.
Figure 3.2 shows good agreement between the simulated mean arterial pressure and
the pressure collected in rats on 2% NaCl diet (about 5 times the normal diet) that
began receiving AngII infusion which doubled their plasma AngII levels [76]. No scaling
of data was performed. Note that we focus here only on the onset phase of the prole
shown in Panel B; the maintenance phase of this experimental response is the subject
of the following section.
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Figure 3.2: Arterial pressure during the onset phase of the "High AngII + High salt"
protocol (panel A) as compared to experimental data from [76] (panel B). In Panel A
the data from rats on 2% NaCl diet (white squares) is overlayed on top of the simulated
arterial pressure response (black line).
Figure 3.3 shows the comparison of the hemodynamic prole reported by Krieger et
al [62]. In this study, the order of AngII and sodium perturbation was reversed: the
animals were rst put on a continuous infusion of AngII and after a stabilization period
the sodium intake was increased. The simulation of this scenario is shown in Figure
3.3, A. Note that the steady states of the response are the same as in Figure 3.1, right
panel, but the initial conditions are dierent, due to the change in the order of AngII
and salt intake perturbations. The experimental data (except for arterial pressure) is
re-scaled to the initial states when overlayed on top of the simulated data in Panel A.
Krieger's study did not report daily changes in blood volume due to technical diculties
of measuring it sequentially. However, the change in blood volume was measured on
Day 2 of the experiment as an 11% increase from normal, which corresponded to 500
g weight increase on that day. We have assumed that this relationship applies for the
other days of the study and re-scaled the data to rodent values using the initial state of
the simulation as normal.
The model prediction and data agree well for arterial pressure. For cardiac output
and blood volume the model predicts higher than observed values. For total peripheral
resistance the prediction disagrees with the data: Krieger observes continuous rise in
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Figure 3.3: Hemodynamic prole during the onset phase of the AngII-salt hypertension
("High AngII + High salt" scenario). Simulated response (Panel A, black lines) is
compared to the experimental data from [62] (panel B). The data is also overlaid on
top of the simulated responses (Panel A, white squares).
resistance, while the model predicts transient decline and lower steady state. Note rst,
that resistance is not a measured but a calculated value in experiments (ratio of arterial
pressure to cardiac output), thus the disparity in the results for resistance and cardiac
output are related. Note also, that the disagreement is driven by the dierence in the
initial states between the simulation and the experiment. High level of AngII has been
shown to increase total peripheral resistance by 40% both in our simulation ("High
AngII + Normal Salt", Figure 3.1, left panel) and experimental studies (see Table
3.1). However, in Krieger's experiment no vessel constriction response to the infusion
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of AngII was reported. It is possible that an exaggerated cardiac output response in
our simulation may be due to the model of Frank-Starling law we used. On the other
hand, our predicted prole for all four variables agree with Guyton's stylized summary
of studies like Krieger's (see Figure 1.4, Panel B). Thus, additional experimental data
may be needed to explain the disparity in the results.
3.2.4 Auxillary simulation data
The following gures provide additional simulation results for the acute system response
to the three scenarios discussed earlier. See Section 3.2 for details.
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Figure 3.4: Response of the key variables of the Circulatory Module to "High AngII +
Normal salt" scenario. See Section 3.2 for details.
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Figure 3.5: Response of the key variables of the Whole-Body Exchange Module to "High
AngII + Normal salt" scenario. See Section 3.2 for details.
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Figure 3.6: Response of the key variables of the Renal Module to "High AngII + Normal
salt" scenario. See Section 3.2 for details.
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Figure 3.7: Response of the key variables of the Circulatory Module to "Normal AngII
+ High salt" scenario. See Section 3.2 for details.
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Figure 3.8: Response of the key variables of the Whole-Body Exchange Module to
"Normal AngII + High salt" scenario. See Section 3.2 for details.
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Figure 3.9: Response of the key variables of the Renal Module to "Normal AngII +
High salt" scenario. See Section 3.2 for details.
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Figure 3.10: Response of the key variables of the Circulatory Module to "High AngII +
High salt" scenario, with AngII infusion started after the change of sodium intake. See
Section 3.2 for details.
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Figure 3.11: Response of the key variables of the Whole-Body Exchange Module to
"High AngII + High salt" scenario, with AngII infusion started after the change of
sodium intake. See Section 3.2 for details.
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Figure 3.12: Response of the key variables of the Renal Module to "High AngII +
High salt" scenario, with AngII infusion started after the change of sodium intake. See
Section 3.2 for details.
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Figure 3.13: Response of the key variables of the Circulatory Module to "High AngII
+ High salt" scenario, with AngII infusion started before the change of sodium intake.
See Section 3.2 for details.
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Figure 3.14: Response of the key variables of the Whole-Body Exchange Module to
"High AngII + High salt" scenario, with AngII infusion started before the change of
sodium intake. See Section 3.2 for details.
89
0
10
20
30
40
Plasma AngII, pg/ml
203%
4
6
8
10
12
Renal blood flow, ml/min
95%
4
6
8
10
12
Afferent resistance, mmHg.min/ml
133%
0
5
10
Plasma aldosterone, pg/ml
117%
1
1.5
2
2.5
Glomerular filtration rate, ml/min
154%
2
4
6
8
10
Efferent resistance, mmHg.min/ml
151%
0
2
4
6
Plasma vasopressin, pg/ml
455%
0.8
1
Proximal reabsorption rate, ml/min
114%
0
5
10
Sodium excretion, mOsm/day
501%
0 1 2 3 4 5 6 7
0
50
100
150
200
Plasma ANP, pg/ml
179%
Time, days
0 1 2 3 4 5 6 7
0
0.5
1
1.5
Distal reabsorption rate, ml/min
248%
Time, days
0 1 2 3 4 5 6 7
0
10
20
30
Water excretion, ml/day
100%
Time, days
Figure 3.15: Response of the key variables of the Renal Module to "High AngII + High
salt" scenario, with AngII infusion started before the change of sodium intake. See
Section 3.2 for details.
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3.3 Global sensitivity analysis
The early response of the system which does not include any of the competing hypotheses
of either renocentric or neurocentric theory, shows at most a modest elevation in arterial
pressure. Thus, some of the variables could be modied slowly and over a long-term
so that further elevation of arterial pressure is observed. One way to identify such
variables is to consider the Circulatory Module, the module which directly determines
arterial pressure, and nd which of its inputs and parameters have the largest impact
on its steady state. Global sensitivity analysis (GSA) is a well-suited technique for this
purpose, capable of addressing the uncertainty of model parameters and identifying key
parameters and interactions which inuence the model outcome the most. To apply
the technique, a specic feature of the model's solutions (the output factor) has to be
chosen and all parameters and inputs that may aect the feature (the input factors)
listed along with their uncertainty ranges. For further details on the method and a
simple example see Appendix B.
The steady state solutions of the Circulatory Module are the solutions of the follow-
ing system of implicit algebraic equations derived from (2.1)-(2.4):
CO  PA   PC
RAS
  RBF = 0
PC   PS
RCS
  PS   PV
RVS
= 0
PS   PV
RVS
+ bJV,IF-P +RBF  CO = 0
CA  PA + CS  PS + CR  PR + CV  PV = VStr
where VStr = VB   VUnstr is the stressed volume of the vascular system and other
variables as introduced in Section 2.2.
The system can be solved for the following variables: PA, PV , PS , and PC , so that
the rest of the variables can be considered input factors which aect these solutions.
However, only two of the pressures, PA and PV , inuence other modules of the system
(see Figure 2.1). Thus we denote them as the output factors for the global sensitivity
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analysis below.
The input factors to the Circulatory Module are comprised of the internal param-
eters and inputs from other modules (Table 3.3). All distributions are assumed to be
normal distributions with a default 20% deviation from the input's normal value. The
deviation is then adjusted if there are available experimental measurements in animals
or humans with hypertension under two conditions: acute stimulation of neural control
(e.g. electrical stimulation of carotid baroreceptors, infusion of epinephrine); or natural
variation with age or time of day.
Input
factor
Distribution Deviation from normal References
CA U(0:007; 0:01) (-20%, +10%) [98], [90]
CR U(0:103; 0:162) (-30%, +10%) [98], [90], [60]
CS U(0:165; 0:289) (-20%, +40%) [98], [90], [60]
CV U(0:188; 0:344) (-40%, +10%) [98], [90], [60]
HR U(320; 480) (-10%, +15%) [57], [60]bJV,IF-P U(0:006; 0:009) (-20%, +20%) default
pCO,1 U(0:4; 0:6) (-20%, +20%) [30], [31], [35], [60]
pCO,1 U(0:64; 0:96) (-20%, +20%) [30], [31], [35], [60]
pCO,2 U(0:532; 0:798) (-20%, +20%) [30], [31], [35], [60]
PR U(18:8; 28:2) (-20%, +20%) default
RAS U(1:197; 1:796) (-10%, +35%) [30], [60]
RCS U(0:017; 0:025) (-20%, +20%) default
RVS U(0:149; 0:223) (-20%, +20%) default
RBF U(5:06; 10:12) (-45%, +10%) [60]
VStr U(5:76; 9:6) (-10%, +50%) [80], [81], [35]
Table 3.3: Inputs to the Circulatory Module and their distributions.
The results of the GSA are shown in Table 3.4 and lead to the following conclusions:
1. There are no signicant interactions between the factors since the main and the
total eects are almost equal for each factor.
2. Arterial pressure is most sensitive to stressed blood volume and venous compliance
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as well as the extra-renal resistance and pressure in renal peritubular capillaries.
In particular, this implies that unstressed blood volume and extra-renal arteriolar
diameter are among the top impact factors for the arterial pressure.
3. Venous pressure is sensitive to the above factors, and also to the parameters of
governing cardiac output.
4. All other factors do not play a signicant role in altering pressures.
Input Arterial Pressure, PA Venous Pressure, PV
factor Main eect, S1 Total eect, ST Main eect, S1 Total eect, ST
VStr 0.54 0.55 0.49 0.51
CV 0.26 0.27 0.23 0.24
PR 0.09 0.09 0.08 0.09
RAS 0.06 0.07 0.01 0.01
RVS 0.04 0.04 0.05 0.05
k1 (CO) 0 0 0.10 0.10
k2 (CO) 0 0 0.02 0.02
k3 (CO) 0 0 0.01 0.01
CA 0 0 0 0
CR 0 0 0 0
CS 0 0 0 0bJV,IF-P 0 0 0 0
RBF 0 0 0 0
RCS 0 0 0 0
HR 0 0 0 0
Sum 0.99 1.02 0.98 1.02
Table 3.4: Global sensitivity results for the Circulatory Module: Main and total eects
ordered roughly in the descending order of signicance.
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3.4 The maintenance phase of hypertension
Out of the three scenarios considered in the previous section, only "High AngII + High
Salt" scenario generates the trigger to the slow increase in the sympathetic nerve ac-
tivity: simultaneous elevation of plasma AngII and plasma osmolarity. The unstressed
blood volume and the extra-renal arteriolar diameter are among top factors which im-
pact the steady state arterial pressure in the fast subsystem. These two variables were
chosen as the two slow variables of the model, driven by the sympathetic activation,
based on indirect experimental evidence (see Chapter 1). The following section demon-
strates the impact of changes in the unstressed blood volume and extra-renal arteriolar
diameter on the maintenance phase of the hemodynamic prole of AngII-salt hyperten-
sion.
Most experimental studies collect daily data only for a few days, due to experimental
diculties in making measurements in conscious animals for a prolonged period of time.
However, there are two experimental studies in rats on AngII-salt protocol which have
collected daily data for duration of about 3 weeks. They show an additional rise in
arterial pressure of about 20 mmHg during the maintenance phase, i.e. after the rst 4-
5 days of the protocol (Figure 3.16). This rise cannot be explained by the fast subsystem
which settles to a steady state by Day 5 or so (see Figure 3.3). We hypothesized that
the rise in arterial pressure is due to a slow decrease in extra-renal arteriolar diameter
alongside a slow decrease in the unstressed blood volume, both of which are driven by
the sympathetic nervous system.
These studies did not measure any other components of the hemodynamic prole
and we are not aware of other studies that reported those values in rodents. However,
a qualitative behavior during the maintenance phase of AngII-salt hypertension was
summarized by Guyton based on sparse measurements in canines (Chapter 1, Figure
1.4) shown here again for reference (Figure 3.17). Since the dynamics of the mainte-
nance phase is not well known due to technical diculties of long-term measurements
in conscious animals we focus on model predictions of the steady state behavior of the
hemodynamic prole.
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Figure 3.16: Arterial pressure response to AngII-salt hypertension in rats on various
sodium diets. Panel A shows data from King and Fink [57], Panel B shows data from
Osborn and Fink [76]. In animals on high salt diet (black squares in both panels) a
latent increase in arterial pressure of about 20 mmHg is observed between Day 5 and
Day 20 of the protocol.
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Figure 3.17: Stylized summary of the hemodynamic prole based on the responses from
several similar studies in canines. Figure modied from [38]. Values show percentage of
the normal steady state.
The simulated response of our model is shown in Figure 3.18. It assumes that the
latent sympathetic activation decreases the unstressed volume by 1.1 ml (86% of normal)
and extra-renal arteriolar diameter by 12 microns (30% of normal) . The results show
the expected directional change in all hemodynamic variables: cardiac output and blood
volume return back to normal values, total resistance increases further, and arterial
pressure reaches levels observed in the studies by Osborn and Fink. The dierences
with the intermediate values of Guyton's stylized prole (i.e. the values at the end of
the onset phase) are due to the dierences between the fast subsystem and Guyton's
observations. The latent phase, however, agrees well with the expected behavior.
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Figure 3.18: Hemodynamic prole of the system to "High AngII + High Salt" scenario,
including latent activation of the sympathetic nervous system (SNS). The relative change
from normal at the end of the onset phase and the end of the maintenance phase are
stated and denoted by black-lled circles. The dynamics of the maintenance phase is
omitted, changes in quasi-steady states of the fast subsystem due to sympathetic drive
are shown by arrows.
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The magnitude of the decreases in the unstressed volume and arteriolar diameter
were chosen based on two principles: 1) they are within the expected range of change
based on the indirect experimental data; 2) change in both variables is needed in order
to explain why cardiac output returns to normal levels. Let us explain this in more
detail.
The expected range of change in the extra-renal resistance is derived from the fol-
lowing: 1) total peripheral resistance has to increase; and 2) renal denervation does
not disrupt the hypertensive response thus the increase is mostly due to the extra-renal
vessels. If one is to expect a 155% increase from normal arterial pressure (in rodent
experiments mentioned above) and a minimal change in cardiac output (Guyton's obser-
vation) and assuming all other variables remain roughly the same, then the extra-renal
resistance would have to increase by about 155%. In our model, this would translate to
a decrease in extra-renal arteriolar diameter by about 15 microns.
The decrease in the unstressed blood volume due to increased venous tone is hy-
pothesized based on the experimental observations of increased mean circulatory lling
pressure in AngII-salt protocol as reported in [57]. The mean circulatory lling pressure
(MCFP) is dened as the mean pressure in the vascular system at zero cardiac output.
When ow through the system stops, the volume redistributes across all vascular com-
partments so that all pressures are equalized. It can be expressed as:
MCFP =
VB   VUnstr
CT
where VB is the total blood volume, VUnstr is the unstressed blood volume, and CT is the
total vascular compliance. Thus, if total compliance and blood volume is unchanged,
the increase in MCFP implies a decrease in the unstressed blood volume.
In the study by King and Fink [57] conducted in rats on the AngII-salt protocol,
it was observed that by Day 14 the total blood volume remained normal but MCFP
had increased by about 50%, from 6.5 to 9.8 mmHg. In the current model, assuming
that all other variables are unaected, that would translate into a 60% decrease in the
unstressed volume, from 8 to 4.7 ml.
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The ranges derived above are only rough estimates and do not consider the con-
comitant eect of changes in other variables of the system. To derive the values for
the simulation in Figure 3.18 we have simulated responses across a range of changes in
the unstressed blood volume and arteriolar diameter. The summary of these results are
shown in Figures 3.19 and 3.20 which show the same data in two dierent views for ease
of interpretation.
Figure 3.19: Steady state responses of the hemodynamic prole variables. Each curve
represents values across a range of the unstressed blood volume VUnstr changes for a xed
decrease in the extrarenal arteriolar diameter (dAS , microns). The black diamond
shows the state of the system at the end of the onset phase of AngII-salt hypertension.
Horizontal dashed grey line indicates the expected values of each of the hemodynamic
variables by the end of the maintenance phase (level for arterial pressure is taken from
studies of Osborn and King, and the rest are chosen from Guyton's studies (see text for
detail).
A decrease in either unstressed volume or extrarenal arteriolar diameter leads to a
similar directional change in the three of the four hemodynamic responses: an increase
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Figure 3.20: Steady state responses of the hemodynamic prole variables. Each curve
represents values across a range of the decrease in extrarenal arteriolar diameter (dAS)
for a xed value of the unstressed blood volume (VUnstr, ml). The black diamond
shows the state of the system at the end of the onset phase of AngII-salt hypertension.
Horizontal dashed grey line indicates the expected values of each of the hemodynamic
variables by the end of the maintenance phase (level for arterial pressure is taken from
studies of Osborn and King, and the rest are chosen from Guyton's studies (see text for
detail).
in arterial pressure and total resistance, and a decrease in blood volume. However,
cardiac output is aected in the opposite directions: a decrease in the unstressed blood
volume elevates it, and a decrease in the diameter lowers it. While a decrease in the
diameter drives expected qualitative changes in all four hemodynamic variables, it does
not have a sucient impact expected from experimental data. Thus, a decrease in both
unstressed volume and extrarenal arteriolar diameter is needed based on experimental
and mathematical considerations.
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3.5 Pressure-natriuresis phenomenon
The pressure-natriuresis phenomenon was observed experimentally by varying salt in-
take and measuring long-term changes in arterial blood pressure and sodium excretion
(Figure 3.21, Panel A; see also Chapter 1, Figure 1.6). For the measurements done
in animals without aecting their plasma AngII the curves look almost at, but when
plasma AngII is maintained at higher levels the curves have a signicant slope.
Figure 3.21: Pressure-natriuresis relationship observed in a study by DeClue et al [23]
(Panel A) and via model simulations (Panel B). The x-axis on the left plot was relabeled
assuming that 5 mEq/kg/day is a normal intake. On both panels, the response of
arterial pressure to salt intake is shown for normally controlled AngII (black line) and
when plasma AngII is elevated (dashed line). On Panel B a further distinction is added:
the response with the latent activation of the sympathetic nervous system, SNS (dashed
line) is compared to the response in the absence of the SNS activation (dotted line).
The arrow shows the incremental change in slope due to the SNS activation.
We simulate this experiment by generating the quasi-steady states of the system
by varying sodium intake from normal to a 5-fold increase. Since plasma osmolarity is
dependent on the level of sodium intake, we assume there is a linear dependence of the
magnitude of the latent sympathetic activation on sodium intake. It can be expressed
as follows:
fSI =
JNaCl,I-P
JNaCl,I-P,0
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SNA =   (fSI  1)  ( AngII
AngII,0
  1)
VUnstr = 8  1:1  SNA
dAS = 12  SNA
where fSI is the fractional increase in sodium intake, SNA is the sympathetic nerve
activity, JNaCl,I-P is the current sodium intake and JNaCl,I-P,0 is the normal sodium
intake, AngII and AngII0 are the current and normal plasma AngII levels respectively,
VUnstr is the unstressed blood volume, and dAS is the decrease in extrarenal arteriolar
diameter. The coecient  is the sensitivity of sympathetic activation to its triggers of
elevated plasma AngII and sodium intake.
Figure 3.22 shows the three-dimensional surface of the arterial pressure steady states
in "High AngII + salt" scenario where salt intake ranges between 1- and 5-fold normal
and the sensitivity of sympathetic activation  ranges between 0 and 14 .
Figure 3.22: Three-dimensional view of the steady state arterial pressure as a function
of sodium intake and sensitivity of the sympathetic system. The left panel shows results
of assuming 2-fold elevation of plasma AngII and the right panel shows results under
the assumption of normally controlled AngII levels. Here, the sympathetic system is
not activated and thus the gradient of arterial pressure is zero in its plane. Sodium
excretion which is equal to the sodium intake in steady state is expressed as a fraction
of normal sodium intake. Sympathetic sensitivity, , is shown on the other axis. See
text for details on line plots.
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In Figure 3.22 three specic solutions are shown. First solution (Panel A, dashed
line) is obtained by taking AngII = 2  AngII0 and  = 14 . Note that when fSI = 5,
VUnstr = 6.9 and dAS = 12 which were the values chosen for our hemodynamic prole
simulation of AngII-salt hypertension (Figure 3.18). Second solution (Panel A, dotted
line) is obtained by taking AngII = 2  AngII0 and  = 0. It represents the system's
response if the latent activation of SNS does not occur. Finally, the third solution (Panel
B, solid line) is obtained by taking AngII = AngII0 ( is assumed 0). It represents the
normal system response to changes in sodium intake.
When these three solutions are projected on the plane of sodium excretion versus
arterial pressure, they depict the pressure-natriuresis phenomenon similar to the one ob-
tained in DeClue's study (Figure 3.21, Panel B - the line marking is kept the same). The
added distinction between pressure-natriuresis curves under the assumptions of present
versus absent latent activation of the sympathetic nervous system (dashed vs dotted
lines in Panel B) show that the change in slope of the pressure-natriuresis curve cannot
be fully attributed to a direct renal control. In other words, pressure-natriuresis curves
are a two-dimensional reection of a complex higher-dimensional dynamics and thus
reect a combination of various direct controls involved in blood pressure regulation.
We will discuss the implication of this result in further detail in Chapter 4.
Chapter 4
Conclusions
This thesis presents a mathematical model of long-term blood pressure control which ex-
plains how activation of the sympathetic nervous system in AngII-salt model
of hypertension can lead to chronic blood pressure elevation without modify-
ing renal excretory function. Prior to the completion of this work and its associated
publications, mathematical models of hypertension were built on the assumption that
such modication is necessary. These old models stem from work by Guyton and Cole-
man in 1970's (GC model) which postulated that there is a direct control of sodium
excretion by arterial pressure via complex intra-renal processes, the so-called chronic
pressure-natriuresis mechanism. The construct of the GC model is based on two key
observations: 1) chronic arterial pressure and sodium excretion are positively correlated,
and 2) articially reducing renal perfusion pressure while simultaneously infusing AngII
leads to the development of hypertension. The correlation between pressure and sodium
excretion has been observed to have dierent slopes under various conditions. The GC
interpretation of these observations has been that the resulting change in blood pressure
must be due to those conditions directly aecting renal ability to excrete sodium and
unless renal ability is disabled, hypertension cannot occur. The GC model is built
to operate under the assumption of sole renal dominance, i.e. that there
is a direct mechanistic eect of arterial pressure on renal sodium excretion
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and this eect must be modied in order to cause all types of hyperten-
sion. In order to explain the long-term elevation in peripheral resistance associated
with hypertension, the GC model also added a hypothesis that there is a whole-body
autoregulation mechanism which converts early elevation of cardiac output into chronic
elevation of peripheral resistance.
Our model is based on a dierent assumption, that renal ability remains
unaected beyond its normal response to AngII, but sympathetic nervous
system activity is slowly amplied over time and ultimately drives hyper-
tension via non-renal inuences. This assumption represents recent experimental
evidence which demonstrates the ndings in AngII-salt induced hypertension: 1) sympa-
thetic activity is chronically elevated; 2) blocking sympathetic activity leads to attenua-
tion of hypertension, and 3) renal sympathetic activity is not involved in altering chronic
blood pressure. In particular, the new evidence implicates long-term sympathetically-
mediated increase in extra-renal resistance and decrease in venous capacitance as the
main drivers of hypertension.
These observations are modeled by rst representing major well-known physiolog-
ical mechanisms involved in blood pressure and uid volume control by incorporating
detailed functions of sodium excretion, uid and solute exchange across tissues, circula-
tory dynamics, and short-term neural control. This representation is similar to that of
the GC model or its later variations, except that it does not include its two key mech-
anisms: chronic pressure-natriuresis and whole-body autoregulation. In particular, the
present model demonstrates renal function which is capable of sensing sodium intake
without relying on a single controller. This renal model describes excretory function
in a combination of physiologically-based and phenomenological descriptions based on
the available experimental knowledge. It is aected by several external controllers, such
as hematocrit, plasma protein concentration, plasma osmolarity and arterial pressure.
The only direct impact that arterial pressure has on the renal function is modulation
of renal blood ow which is buered by myogenic constriction of aerent arterioles.
There are no other eects of arterial blood pressure on renal ltration or reabsorption.
The model also includes latent activation of sympathetic nervous system triggered by
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increased plasma AngII and sodium. The sympathetic nervous system does not im-
pact renal function directly, but instead modies two non-renal parameters: extra-renal
resistance and venous capacitance.
Despite the dierences in assumptions with the GC model, our model's
predictions agree well with all major classical observations associated with
AngII-salt hypertension, including the pressure-natriuresis phenomenon. The
model predicts correct responses to AngII infusion and to sodium intake increases. It
produces key qualitative behavior of the hemodynamic prole of salt-sensitive hyperten-
sion: a chronic elevation in blood pressure and peripheral resistance, with transiently in-
creased blood volume and cardiac output, both of which later return to near-normal val-
ues (Figure 3.18). Finally, the model reproduces the pressure-natriuresis phenomenon.
Specically, it shows that the steady state values of arterial pressure and sodium excre-
tion in the model are positively correlated, and the slope of the correlation is modied
by an infusion of AngII just as it is experimentally observed. But we go further to show
that these slopes are also aected by the degree of sympathetic activation (see Figure
3.21, Panel B), even though there is no direct control of renal excretory function by the
sympathetic system in the model.
This newly proposed model conclusively demonstrates that AngII-salt
hypertension can be maintained without the sole dominance of renal ability
to excrete sodium. This disputes the hypothesis that has been prevailing for more
than 50 years. If one were to consider the new model predictions from the standpoint
of the GC theory, one would conclude that chronically elevated sympathetic activity
is directly aecting renal excretory function. However, this conclusion is inconsistent
with our model which excludes renal sympathetic activity contribution. Thus, one has
to accept that there is another independent contributor to blood pressure elevation,
namely, the sympathetic nervous system.
It is important to note, that the above observations do not entirely exclude
renal involvement in the model. Only about a half of the total blood pressure
response in AngII-salt protocol is due to latent sympathetic activation, while the other
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half is due to mechanisms involved during the onset phase of hypertension. Adminis-
tration of AngII, acting in the opposite of the normal renal function control, does aect
renal ability to excrete sodium during the onset phase leading to volume expansion and
pressure increase. Yet, even then the kidney is not the sole determinant of blood pres-
sure, as AngII constricts all vessels and thus contributes to the elevation of pressure via
a non-renal pathway.
The conclusion that there are several independently important contributors,
such as renal and neural controls, to hypertension development is not surpris-
ing from either physiological or mathematical perspectives. The multifactorial nature
of blood pressure control is widely accepted in physiology. Experimental treatments
of non-renal pathways, such as baroreex stimulation, splanchnic denervation, atrial-
venous shunts, and weight loss, have been shown to be eective in hypertensive subjects.
From a mathematical perspective the conclusion is also natural if one is to expand from
the two-dimensional view of hypertension in the pressure-natriuresis plane to a larger-
dimensional view of several controllers of blood pressure. The newly proposed model has
provided an example of such an approach by showing that the steady state of arterial
pressure in our model can viewed as a 3-D function of sodium intake and sympathetic
activity shown in Figure 3.22. For a chosen level of sympathetic sensitivity, one can
generate a solution from this 3-D surface which projects onto the pressure-natriuresis
plane as a pressure-natriuresis curve shown in Figure 3.21. The slope of this curve is
only partially explained by AngII eects on renal function during the onset phase of
hypertension, while the rest of the change is dependent on the level of sympathetic sen-
sitivity during the maintenance phase. Thus, in our model the pressure-natriuresis
curve, and any other plane projections, is a reection of a combination of in-
dependent control mechanisms and does not imply dominance of any single
control.
This multidimensional view of blood pressure control does not exclude a
possibility of a single control mechanism dominating all the others. The GC
model and its associated experiments have argued that disrupting renal ability to excrete
sodium can cause hypertension. For example, the study by Hall et al. [46] showed
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severe blood pressure elevation when renal perfusion pressure was xed at a constant
level and AngII was infused. Another example is the kidney transplantation studies
showing that blood pressure often follows kidney. However, what the GC model shows in
combination with the present work is that renal dysfunction is sucient for hypertension
development, but is not necessary and experimental studies are supportive. Despite
extensive research over several decades, it remains to be shown that renal dysfunction
is responsible for the majority of hypertension cases. Instead, several non-renal causes
such as sympathetic activation, inammation, and arterial stiening, have gathered
solid experimental evidence in their support [60, 17, 52, 82, 94].
In its current implementation the model is designed and validated for
a specic type of salt-sensitive hypertension, AngII-salt hypertension, and
thus is limited in its direct application to a more general discussion of hyper-
tension. AngII-salt protocol is one among many protocols for studying hypertension,
including infusion of aldosterone-like substance (DOCA-salt), reduction of renal mass,
or by weight-gain (obesity). Moreover, pathways other than neural have also been im-
plicated in hypertension. Thus the model might need be revised, improved, or expanded
to reect the hypotheses of a particular theory. Phenomenological descriptions of renal
processes have been used, and thus the short-term dynamics (within minutes of a stimu-
lus such AngII infusion) needs further validation. More detailed and sophisticated renal
models already exist in the literature as described in Chapter 3 and could be incorpo-
rated into the framework of this model. The model also explicitly excludes sympathetic
control of the renal function. This was a fair assumption for studies of AngII-salt
protocol, where renal denervation did not impact the outcome and it allowed a more
clear emphasis on the extra-renal role of the sympathetic nervous system. However, in
other models of hypertension renal sympathetic activity may play an important role and
should be added to the model. Finally, improvements can be made even for AngII-salt
hypertension. For example, venous compliance, not just the capacitance, is likely to
also be diminished as the consequence of the overall increase of sympathetic stimulation
of veins. The dynamics of the slow sympathetic response and specic neural signaling
pathways require further description but await additional experimental observations.
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Future improvements to the model should address the above limitations
and perform full global sensitivity analysis of the model which can point to
specic critical pathways that should be considered in further expansion of
the model. We have illustrated a simple example toward this approach by performing
a global sensitivity analysis on the circulatory sub-model. This analysis shows that
the key factors which impact blood pressure are stressed volume, venous compliance,
extra-renal resistances, and pressure in renal peritubular capillaries. All of these factors
can be modulated by renal and neural inuences, and some can be aected by other
controls such as inammatory processes and vessel stiening. This nding means that
the control of these factors must be included in the modeling.
Hypertension is a multifactorial disease with a host of factors that can inuence
its development and maintenance. In this dissertation, eort was focused on specic
neural pathways, and thus this mathematical model does not address many of the larger
clinical questions surrounding the mechanisms of hypertension. However, the model
demonstrates how the integrative nature of blood pressure control can be
elucidated in a model if the hypothesis of the chronic pressure-natriuresis
mechanism is omitted. Relaxing this hypothesis does not deny renal involvement
in hypertension, but allows equal representation of other important regulatory mecha-
nisms. This nding may be of particular interest, for example, to the on-going eorts
of multi-scale modeling of body uid homeostasis and blood pressure regulation. The
aim of these ongoing eorts is to "provide an open-source multi-resolution modeling
environment that will permit, at a practical level, a plug-and-play construction of in-
tegrated systems models using lumped-parameter components at the organ/tissue level
while also allowing focus on cellular- or molecular-level detailed sub-models embedded
in the larger core model" [101]. The core model is largely based on the GC model, which
has now been shown to limit the ability of these extensive eorts to identify non-renal
pathways of hypertension. A mathematical model which is able to distinguish between
pathways depending on the experimental data to which it is applied, is a more accu-
rate representation of the complex regulation of long-term blood pressure control, and
will enable future scientists, clinicians, and mathematicians to pursue novel therapeutic
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strategies to treat patients with hypertension.
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Appendix A
Renal physiology
A.1 Renal functions
The kidneys are some of the most complex organs in the body. They possess an intri-
cate anatomical structure, and are under precise physiological control by an astounding
number of various factors. The kidneys play the central role in regulating balance of
water and solutes, and the removal of waste products from the blood. Table A.1 shows
average daily values of sodium and water gains and losses in human adults, under nor-
mal physiological conditions. However, these averages can uctuate dramatically as a
result of changes in diet, water intake, exercise, and the environment. This can disrupt
total body sodium and water balance which is fundamental to basic cellular processes,
and ultimately impacts many organ functions. The kidneys serve to prevent these uc-
tuations from happening by matching gains and losses over an extremely wide range and
doing so quickly and precisely. For example, in human adults urinary water excretion
can match intakes ranging between 0.4 L/day to 25 L/day. Urinary sodium excretion
can adjust to sodium intakes ranging from 0.05 g/day to 25 g/day. The goal of this
chapter is to describe the key anatomical and physiological features underlying renal
control of sodium and water excretion.
Human kidneys receive about 20% of the cardiac output (at rest) and lter about 120
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ml/min of plasma which amounts to about 170 l/day. Such large ltration rate necessi-
tates almost complete reabsorption of key solutes back into circulation. Human kidneys
reabsorb about 99% of ltered water and sodium. Most of the ltered water,  85%, is
reabsorbed passively due to active reabsorption of sodium, while the remaining portion
is under independent control. In humans, the urine ow rate varies between 0.5 to 2.5
L/day and the urine osmolality varies between 300 mOsm/L and 1400 mOsm/L. The
variation of urine ow rate and osmolality are the key features that allow independent
maintenance of both water and sodium homeostasis over wide range of intakes.
Description of the human renal anatomy and physiology will be the focus of the
discussion. However, some rodent anatomy and physiology will also be provided be-
cause much of the experimental data was collected in that animal model, and there are
important dierences between human and rodent renal functions.
A.2 Anatomic structure of the kidneys
A.2.1 Gross features
The two kidneys lie in the back of the abdominal wall, outside the abdominal cavity. The
adult human kidney weigh about 150 grams and is approximately 11 cm by 6 cm by 3 cm
Sodium Water
Total intake 10.5 g 2550 ml
Food 10.5 g 1000 ml
Liquids - 1200 ml
Metabolically produced - 350 ml
Total loss 10.5 g 2550 ml
Skin and lungs - 900 ml
Sweat 0.25 g 50 ml
Feces 0.25 g 100 ml
Urine 10 g 1500 ml
Table A.1: Average daily gains and losses of sodium and water for an average human
[110]. A portion of the sodium may also be stored in inactive form in skin and bones,
which represents another means of sodium loss.
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Figure A.1: Diagram of the cut surface of a bisected kidney, showing important anatomic
structures.
in size. The kidney is surrounded by a tough brous capsule and is supplied by a single
renal artery, a renal vein, the lymphatics, and a nerve plexus. There are two distinct
regions of the kidney (Figure A.1): an outer region (the cortex) and an inner region
(the medulla). In humans, the medulla is divided into 8-18 conical masses (the renal
pyramids), with the apexes extended toward the renal pelvis to form a papilla. The
cortex forms a cap over a base of each renal pyramid and extends downward between the
pyramids. The ureters originate from the lower portion of the renal pelvis and descend
into the bladder. In rats, the medulla has a single renal pyramid.
At the top of each kidney sits the adrenal gland which is mainly responsible for
releasing several hormones: aldosterone, cortisol, androgens, epinephrine, and nore-
pinephrine. These hormones regulate various functions, but aldosterone in particular
plays a major role in regulating renal sodium excretion and will be discussed more in
detail in a later section of this chapter.
A.2.2 Nephron structure
There are several anatomical structures that play an important role in urine formation:
vasculature, renal corpuscle, renal tubule, collecting duct system, interstitium, and two
types of nephrons. The functional unit of the kidney is the nephron. A human kidney
contains about a million nephrons; a rat kidney contains about 30,000 nephrons. Each
nephron consists of a ltering component called the renal corpuscle, and a renal
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Figure A.2: Basic structure of a nephron and renal interstitium.
tubule (Figure A.2). The renal corpuscle forms a ltrate from blood, free from blood
cells and proteins. The ltrate then ows through the renal tubule, where water, sodium,
and substances are judiciously reabsorbed back into the circulation. All nephron tubules
eventually merge into the collecting duct system which drains the remaining ltrate
into the bladder.
The blood is supplied to the kidney via a renal artery which arises o the side
of the abdominal aorta, immediately below the superior mesenteric artery. The blood
is carried away via a renal vein into the ascending vena cava. Once the artery enters
the kidney near the renal pelvis it branches o into segmental arteries which travel up
towards the cortex in the space between renal pyramids (Figure A.1) and then branch
into arcuate arteries which run between the cortex and medulla. They further branch
o at right angles into interlobular arteries which rise into the cortex and continually
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Figure A.3: Diagram of the cut surface of a bisected renal corpuscle and the juxta-
glomerular apparatus.
branch o into the aerent arterioles that supply the renal corpuscles (Figure A.2). The
venous structure is similar and lies adjacent to the arterial structure.
Each renal corpuscle is supplied with blood via an aerent arteriole, which feeds
into a compact cluster of capillaries, called the glomerular capillaries, or glomerulus
(Figure A.3). The blood is then ltered into the renal tubule via a Bowman capsule,
which is a uid-lled capsule surrounding the glomerulus. The remaining blood then
ows through another arteriole, called the eerent arteriole, and then another set of
capillaries, called peritubular capillaries, and into the venous system. The peritubu-
lar capillaries wind around the renal tubule and receive the reabsorbed quantities back
into the general circulation.
The renal tubule consists of three major components (Figure A.2): the proximal
tubule, the loop of Henle, and the distal tubule. The proximal and distal tubules
lie in the cortex and are connected by the loop of Henle which is a hairpin-like tubule
diving down into the medulla. The loop of Henle can be further subdivided into the
descending limb of Henle, the thin ascending limb of Henle, the thick ascend-
ing limb of Henle. The end of the thick ascending limb on Henle of each renal tubule
passes between the aerent and eerent arterioles of that same nephron. At that loca-
tion there is a specialized patch of cells in the wall of the ascending limb called macula
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densa (Figure A.3), and a patch of cells in the wall of the aerent arteriole called
juxtaglomerular (JG) cells. The combination of these two groups of cells is known
as the juxtaglomerular apparatus (JGA). Renal nerve endings innervate smooth
muscle of the aerent arteriole and juxtaglomerular cells. The JGA plays an important
role in control of sodium excretion which will described in a later section.
Once the ltrate passes through the distal tubule it ows into the collecting duct
system and gradually merges with ltrates from other nephrons. The collecting ducts
continue to merge and pass through the medulla to deliver the ltrate to the renal pelvis
(Figure A.2). The renal pelvis is continuous with the ureter draining the kidney into
the bladder.
A.2.3 Two populations of nephrons
The renal corpuscles of all nephrons are located in the renal cortex, but the loop of
Henle of each nephron descends into renal medulla at varying depths. The length of the
loop of Henle allows to dierentiate two major populations of nephrons in the kidney:
those with short loops of Henle, termed cortical or supercial nephrons, and those
with long loops of Henle, termed juxtamedullary nephrons (see Figure A.2). Some
of the cortical nephrons have loops of Henle which remain fully in the cortex. About
85% of nephrons are cortical. This proportion of cortical to juxtamedullary nephrons,
as well as the distribution of blood ow between them, might be playing an important
role in control of sodium excretion. In short, cortical nephrons carry the majority of
bulk reabsorption while juxtamedullary nephrons play a key role in concentrating inner
medulla and thus allow ne-tuning of reabsorption.
There are two more important features that dierentiate cortical and juxtamedullary
nephrons. First, cortical nephrons do not have the thin ascending limb, so that the
descending limb transitions directly into the thick ascending limb; their renal corpuscles
are also located in the upper cortex, while juxtamedullary corpuscles are located in
the lower cortex, near the medulla. Second, the peritubular capillaries of a cortical
nephron surround its proximal and distal tubular segments, so that the capillaries remain
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entirely within the cortex. In contrast, the peritubular capillaries of a juxtamedullary
nephron, called the vasa recta, dive into the medulla following the nephron's loop of
Henle. Eerent arterioles of juxtamedullary nephrons are larger in diameter and possess
thicker walls and smooth muscle layer than the eerent arterioles of cortical nephrons.
The substances reabsorbed from the proximal and distal segments of a juxtamedullary
nephron are picked up by the peritubular capillaries of the nearby cortical nephrons.
Sometimes a third population of nephrons is dened, the midcortical nephrons. The
glomeruli of these nephrons are located in midcortex, their renal tubules are similar
to those of juxtamedullary nephrons (i.e. contain the thin ascending limb), although
they do not dive as deep into the medulla. However, the peritubular capillaries of the
midcortical nephrons reside in the cortex only, similar to the cortical nephrons.
A.2.4 Interstitium
The cortex and the medulla regions of the kidney have dierent osmolar properties. The
cortex has constant osmolality approximately equal to that of plasma. The medulla has
a signicant osmolality gradient so that osmolality is about 4 times higher at the papillae
in humans (9 times in rats). This osmotic gradient is the key factor in kidney's ability to
regulate water and sodium loss. The gradient is maintained even in diuresis, although
it is diminished in magnitude relative to anti-diuresis.
The boundary between the renal cortex and medulla is dicult to identify, but is
usually associated with the location of the branching of interlobular arteries (Figure
A.2). The renal medullary interstitium contains uid, microbrils, extracelluar matrix,
and interstitial cells. The renal medulla can be segmented into an inner medulla and
outer medulla, and the outer zone can be further subdivided into an inner stripe and
an outer stripe. This segmentation is based on the types of nephron segments that
can be found in each zone. The inner medulla contains both descending and ascending
thin limbs and large collecting ducts. In the inner stripe of the outer medulla, thick
ascending limbs are present as well. The outer stripe of the outer medulla contains
the terminal segments of proximal tubules. The remaining portions of the nephron
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(the renal corpuscle, the proximal and distal tubules) lie in the cortex. As will become
evident later, this subdivision of the medulla into zones that contain a subset of tubules
with specic permeability and transport features allows understanding of the processes
that lead to the creation and maintenance of medullary osmolality gradient.
The blood supply of the medulla is derived only from the vasa recta, while the blood
supply of the cortex is derived from the peritubular capillaries of cortical nephrons. The
cortex contains abundant peritubular capillaries and receives a high eective blood ow,
so that the reabsorbed water and solutes are immediately returned to the general circu-
lation. However, in the medulla, capillaries are more sparse and arranged in a parallel
fashion. It provides a means of reducing the eective blood ow to the medulla while
maintaining a high absolute perfusion rate. It slows down the removal of reabsorbed
solutes from the medulla and thus enables its osmotic gradient, the essential feature of
urine concentration discussed below. Medullary blood ow constitutes only 10-15% of
total renal blood ow and is derived from 7-18% of glomeruli (depending on the species).
The capillary plexus in the outer medulla is considerably more dense and much better
perfused than the plexus in the inner medulla and the inner stripe of the outer medulla
receives the largest portion of the medullary ow.
Fluid and plasma proteins can leave the renal interstitium via either capsular lym-
phatics or hilar lymphatics. Knowledge of the distribution of the lymphatics within
the kidney is limited. The lymphatics drain mostly the cortical interstitium and are
embedded in the loose connective tissue around the renal arteries and travel along
the interlobular and arcuate arteries. The medullary interstitium may not have in-
tramedullary lymphatics at all and drain either directly into ascending vasa recta or to
the interlobar lymphatics. The role of the lymphatics is usually not considered in the
discussions of renal function.
A.3 Basic renal processes
In healthy people, urinary sodium excretion changes to match sodium intake within 1 to
3 days. The response is so precise that the total body sodium varies just a few percent
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despite wide uctuations in sodium intake and occasional non-renal losses, e.g. sweating.
However, there are no known receptors of total body sodium. The understanding and
search for particular sodium sensors is an area of active research. Currently it is believed
that renal control of sodium excretion is the result of an indirect sensing of eects of
sodium. Most well-understood control signals to the kidney are triggered by changes in
extracellular uid (ECF) and their eect on cardiovascular pressures, as well as changes
in cell and plasma osmolalities. Since NaCl constitutes nearly 90% of ECF and is
important to many cellular and organ functions, it seems reasonable to assume that the
precise control of NaCl is likely to be tied to the accurate sensing of ECF and osmolality
changes.
Urine formation begins with the glomerular ltration of protein-free, cell-free
uid into the renal tubules. As the ltrate ows through the tubules it is reabsorbed
back into the circulation. The process is called tubular reabsorption and it varies for
each segment of the tubule as well as the substance being reabsorbed. Some substances
are also secreted into the ltrate or metabolized by the tubular cells. Thus, the amount
of water and sodium excreted in the urine is the amount ltered minus the amount
reabsorbed (neither substance is secreted). The kidney's ability to maintain total body
water and sodium balance is determined by its urine concentrating ability which is
driven by the medullary interstitial gradient. The next few sections describe each of the
three key renal processes in detail.
A.3.1 Glomerular ltration
The glomerular ltrate contains no blood cells or proteins, but contains all other plasma
substances in essentially the same concentration as in plasma. The cells and proteins are
excluded for two reasons. First, the fenestrations in the walls of glomerular capillaries
are not large enough for high-molecular-weight substances to pass through. Second, the
ltration pathways are negatively charged and thus oppose the movement of the nega-
tively charged plasma proteins. The exclusion of proteins creates an osmotic gradient
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across glomerular membrane, which becomes crucial for proper ltration and reabsorp-
tion of substances.
Figure A.4: A: Summary of glomerular and peritubular dynamics with representative
values for humans. Arrows show direction and relative amount of water moved across
capillary membranes. While the hydrostatic glomerular capillary pressure remains rel-
atively constant, the colloid osmotic pressure increases from the aerent to the eerent
end, as the protein concentration increases. The increased osmotic pressure in the per-
itubular capillaries creates necessary pressure gradient for water reabsorption from the
interstitium. The osmotic pressure returns to almost normal plasma values at the ter-
minal end of the peritubular capillaries, since almost all ltered water is reabsorbed. B:
Two cases of colloid osmotic pressure proles along glomerular capillaries. Filtration
equilibrium (, solid line) can be achieved at low plasma ow rate, while at high plasma
ow rates ltration pressure remains positive at the eerent end (, dashed line). No-
tation: , colloid osmotic pressure; P , hydrostatic pressure; G, glomerular capillaries;
B, Bowman space; C, peritubular capillaries; I, cortical interstitium.
Filtration across the glomerular capillary walls, called the glomerular ltration
rate (GFR), is determined by the opposing hydrostatic and osmotic forces and the
ltration coecient of the glomerular membrane (Figure A.4):
GFR = KG(PG   PB  G) (A.1)
where KG is the glomerular ltration coecient, PG is the glomerular hydrostatic pres-
sure, PB is the opposing hydrostatic pressure in Bowman's capsule, and G is the
average osmotic pressure in the glomerular capillaries. In humans, ltration continues
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throughout the entire length of the glomerular capillaries and there remains a posi-
tive net ltration pressure at the eerent end of the glomerular capillaries. In rats,
ltration equilibrium maybe achieved before the eerent end so the equation (A.1) has
to be revised to include plasma ow rate which aects the distance to the ltration
equilibrium.
The hydrostatic glomerular capillary pressure is controlled via independent adjust-
ments of the aerent and eerent arteriolar resistances. As the uid is ltered out,
the plasma protein concentration and, hence, the osmotic force, increases toward the
eerent end. The hydraulic permeability of the glomerular membrane may also aect
the ltration although there is no clear consensus on its physiological regulation.
Similarly, reabsorption of water by the peritubular capillaries from the surround-
ing interstitium is determined by the opposing hydrostatic and osmotic forces and the
ltration coecient of the peritubular walls:
PRR = KR(PI   PC   (I  C)) (A.2)
where PRR is the peritubular reabsorption rate, KR is the reabsorption coecient,
PC is the peritubular hydrostatic pressure, PI is the opposing hydrostatic pressure in
the surrounding interstitium, G is the average osmotic pressure in the peritubular
capillaries, and I is the opposing interstitial osmotic pressure.
While the reabsorption of water and solutes from the interstitium into the peritubu-
lar capillaries happens by bulk ow driven by Starling forces (i.e. the movement of uid
due to hydrostatic and oncotic forces), the reabsorption from the renal tubules into the
interstitium is more complex and described in detail in the following section.
A.3.2 Tubular reabsorption
One of the major functions of the kidney is to eliminate waste products from the blood.
Thus the ltered load is enormous compared to the total body values. Since the ltration
happens by bulk ow it would lead to the loss of the important substances, unless
reabsorption rates were almost equally high. The reabsorption of most useful plasma
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components such as water and sodium is almost complete, so that only a very small
fraction of the ltered load is excreted in the urine. Thus, the reabsorption of ltrate
components, termed tubular reabsorption, plays a critical role in urine formation.
Unlike glomerular ltration, tubular reabsorption does not happen by bulk ow, as
there are inadequate pressure dierences and permeability of the tubular membranes.
Instead, the reabsorption happens either by diusion or mediated transport. Once a
reabsorbed substance moves from the tubular lumen to the interstitial uid it is picked
up by the peritubular capillaries. This movement occurs by a combination of diusion
and bulk ow, driven by the capillary Starling forces (Figure A.4).
The majority of reabsorption of both water and solutes happens in the proximal
tubule (Table A.2 and Figure A.5). Henle's loop also reabsorbs relatively large quantities
of major ions, and some water. Thus the proximal portion of the tubule (near macula
densa) does the major reabsorption work, removing about equal portion of water and
sodium so that the ltrate is nearly isosmotic when it arrives to the distal portion of the
tubule. The distal segments of the nephron (distal tubule and collecting ducts) perform
ne-tuning of the reabsorption of most substances. Thus, most homeostatic controls
act upon the distal segments of the tubule.
Segment Inow ml/min Reabsorbed ow as a fraction of GFR
The proximal tubules 125 0.64
The descending limb of Henle 45 0.16
The ascending limb of Henle 25 0
The distal tubules 25 0.10
The collecting ducts 12 0.08 (0.02..0.09)
The bladder 1 (10..0.4) -
Table A.2: Normal reabsorption rates within a human nephron (based on [42] and [2]).
Values in parentheses reect the range of values in diuresis (large water loss) and anti-
diuresis (restricted water loss). Note that the adjustment of water loss happens almost
entirely in the nal tubular segments - the collecting ducts.
Tubules may also move substances directly from peritubular capillaries into the
tubular lumen by a process termed tubular secretion. It is usually coupled in some
way to the reabsorption of sodium. The most important substances secreted by the
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tubules are hydrogen ions, potassium, and creatinine. Secretion helps improve the
ltering eciency of the kidney. However, since it plays a minor role compared to other
mechanisms at play, it will not be discussed further.
The water and solutes can be transported across a tubular wall by either tight
junctions between the cells or through the epithelial cells themselves. They rst move
from the tubular lumen into the cell across its luminal membrane, and then from the
cell into the interstitium across its basolateral membrane. In all sodium-reabsorbing
tubular segments, sodium reabsorption happens via the active transport of sodium out
of the epithelial cells into the interstitial uid. This transport is achieved by Na/K-
ATPase pumps in the basolateral membrane of the cells. Active transport also ensures
low sodium concentration within the cells and thus encourages sodium diusion from the
tubular lumen into the cells across their luminal membrane. The mechanism of sodium
movement across the luminal membrane, however, varies from segment to segment. For
example, in the proximal tubule it occurs either by cotransport with an organic molecule
(such as glucose) or by countertransport with hydrogen ions. In the cortical collecting
duct, the diusion occurs through sodium channels. Dierent types of transport allow
reabsorption of various substances and exibility in sodium excretion control.
As sodium and other solutes are removed from the tubular lumen, the local (near
the epithelial cell) osmolality in the lumen lowers and local osmolality of the interstitial
uid rises. Water diuses passively by osmosis from the lumen into the interstitial uid
either across the epithelial cells or tight junctions. Water movement can happen only
if the epithelium is permeable to water. The water permeability varies across dierent
tubular segments and depends largely on the presence of aquaporins, which are the
water channels in cell membranes. The last portions of renal tubules, the cortical
and medullary collecting ducts, have varying water permeability which is controlled by
vasopressin (also called antidiuretic hormone, or ADH), a peptide hormone secreted
by the posterior pituitary. Vasopressin stimulates the insertion of aquaporins into the
luminal membrane of epithelial cells.
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A.3.3 Urine concentration
The human kidney can produce urine of varying osmolality, as high as 1400 mOsm/L,
but it is typically around 600 mOsm/L. This is 2-5 times higher than the plasma os-
molality of 290 mOsm/L. The kidney's ability to create an interstitial uid osmolality
gradient from cortex to the inner medulla is the key to urine concentration and main-
tenance of total body water and sodium balance. Let us for now assume that the
interstitial gradient is maintained and consider how the reabsorption of sodium and
water is handled along dierent tubular segments. Two extreme cases of large water
loss (diuresis) and restricted water loss (anti-diuresis) will be considered to illustrate the
importance and contribution of various segments. Water and sodium permeabilities of
all renal tubule segments as well ltrate osmolality and interstitial osmolality gradient
are schematically shown in Figure A.5. Table A.2 shows relative reabsorption rates of
water in each tubular segment.
As mentioned earlier, tubular segments prior to macula densa site are responsible
for bulk water and sodium reabsorption, while the distal segments ne tune the excre-
tion rates. Thus, the earliest site along the nephron where dierences in tubular uid
osmolality between diuresis and anti-diuresis can be detected is towards the end of the
distal tubule. Here, the tubular uid is isosmotic with plasma during anti-diuresis and
hypotonic during diuresis. In the nal segment of the inner medullary collecting duct
the tubular uid osmolality remains hypotonic during diuresis, and rises to levels above
plasma osmolality during anti-diuresis. The chief site for water dilution is the loop of
Henle and this dilution process happens in either diuresis or anti-diuresis. Further urine
dilution or concentration occurs in the collecting ducts, where it is mostly controlled
by vasopressin. Sodium and water permeability properties of each tubular segment are
briey described below.
The proximal tubule is a site of major isosmotic reabsorption; it actively reabsorbs
about 60-70% of sodium and a similar portion of water by osmosis. The descending limb
of the loop of Henle is almost completely impermeable to sodium and allows passive
reabsorption of water only as it descends into the medullary regions of progressively
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Figure A.5: Summary of water and sodium transport in a juxtamedullary nephron. The
ltrate osmolality at the proximal end of each tubular segment is shown in white boxes.
The interstitial osmolality gradient is shown in the axis on the left. Two scenarios, of a
diuresis (large water loss) and anti-diuresis (restricted water loss) are shown. Majority
of water control is done in medullary collecting ducts and is closely linked to the inner
medullary osmolality. See also Table A.2.
increasing osmolality. On average, by the end of the loop about 15% of ltrate uid is
reabsorbed in this segment and the ltrate osmolality is increased about 4-fold. The
permeability properties depend on the depth of the limb in the inner medulla and
whether it belongs to a supercial or a long-looped nephron. The permeability is mostly
driven by the presence of aquaporin water channels, which are expressed along the length
of the descending limb in gradually decreasing numbers. The epithelium of descending
limbs in the outer medulla has the highest aquaporin content and thus highest water
permeability. The water permeability of descending thin limbs in the middle part of
the inner medulla is about 42% that of outer medullary thin descending limbs. These
changes in water permeability are accompanied by a progressive increase in sodium
permeability, although it is considerably less than that of the ascending thin limb.
Supercial nephrons have a short descending limb within the inner stripe of the outer
137
medulla. A segment of the descending limb right before it joins the thick ascending limb
has no aquaporin channels and its water permeability is essentially zero.
The thin ascending limb has very high permeability to NaCl and almost zero water
permeability. Passive reabsorption of Na happens mostly via paracellular Na transport,
and Cl is reabsorbed via transcellular transport. Active transport of Na is almost non-
existent, adding up to only about 2% of Na reabsorption by all thin ascending limbs. The
thick ascending limb (TAL) is water impermeable and reabsorbs about 30% of ltered
sodium via active transport. This is a critical component of the renal countercurrent
multiplication system, a specic mechanism which creates and maintains the required
medullary concentration gradient. The TAL begins after the ascending limb of long-
looped nephrons and after the aquaporin-poor segment of short-looped nephrons. The
TAL reaches into the renal cortex, near the parent glomerulus, and joins the distal
tubule.
The distal convoluted tubule (DCT) provides the nal ne-tuning of urinary sodium
excretion. The DCT is located in the cortex and continues to actively transport sodium
with minimal loss of water (in the absence of vasopressin). Its regulation of sodium
reabsorption plays a critical role in controlling the amount of sodium excretion. It
reabsorbs about 7-10% of ltered NaCl. Eventually the hypotonic ltrate enters the
collecting duct which starts to descend into the hyper-concentrated medulla once again
where the nal ne-tuning of water excretion is done. The duct walls are impermeable
to sodium and their permeability to water is strongly inuenced by vasopressin, allowing
for a wide range of water reabsorption control. Water is passively drawn out into the
medullary interstitium via aquaporin channels. The medullary collecting duct is always
slightly permeable to water, even in the absence of vasopressin.
Although the previous sections have adequately described how the kidney regulates
sodium and water excretion and absorption, it is important to understand that tubular
wall permeabilities and transport properties can be adjusted via various mechanisms.
These include mechanistic, hormonal, or neural factors and are described in more detail
in later sections. The next few sections deal with the mechanisms behind the interstitial
osmolality gradient which ultimately controls urine concentration.
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Table A.3: Composition on plasma, papilla, and urine during diuresis and anti-diuresis
in rats (in mmol/L) [93].
Component Plasma Papilla Urine
Diuresis (urine ow ' 192L/min)
Sodium 138 159 5
Urea 4.5 34 23
Osmolality 304 572 59
Anti-diuresis (urine ow ' 5L/min)
Sodium 145 417 148
Urea 4.4 605 946
Osmolality 314 1832 1805
A.3.4 Interstitial osmolality gradient
The axial osmolality gradient in the renal medulla is composed of gradients of several
solutes, mostly NaCl and urea. In the outer medulla the gradient is primarily maintained
by the increase in NaCl concentration. In the inner medulla the gradient is mostly due to
the increase in urea concentration. In the steady state there is mass balance for every
substance that enters and leaves the medulla via tubules or blood vessels. However,
during physiological perturbations the medullary osmotic gradient can change due to
transient accumulation or washout of solutes (e.g. see dierences between diuresis and
anti-diuresis shown in Figure A.5 and Table A.3). In the following, we discuss the
well-understood mechanisms contributing to the development of the medullary osmotic
gradient (see summary in Figure A.6) and then briey address remaining open questions.
Generation of NaCl gradient in the renal outer medulla
The renal outer medulla contains descending and thick ascending portions of jux-
tamedullary nephrons, entire loops of Henle of the cortical nephrons, and segments of
collecting ducts and vasa recta (see Figure A.2). Thick ascending limbs actively pump
sodium into interstitium, while descending limbs and collecting ducts allow only water
movement across their walls. The vasa recta is highly permeable to both sodium and
water. These varying permeability properties and parallel arrangement of vessels play
an important role as described below (see also to Figure A.6).
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Figure A.6: Water, NaCl, and urea transport responsible for the creation of the
medullary osmolality gradient during anti-diuresis. In the outer medulla the gradient
is created by the active NaCl transport (green/gray solid arrows) from thick ascending
limbs to interstitium. Most of the sodium is trapped via a countercurrent exchange
in the vasa recta (green striped arrows). In the inner medulla gradient can be fur-
ther enhanced by urea accumulation. During anti-diuresis, vasopressin-induced water
reabsorption in the collecting ducts leads to a signicant increase in ltrate's urea con-
centration and urea diusion into the interstitium (purple-dotted arrows). Most of the
urea is recycled through the distal portion of the nephron and some is trapped via a
countercurrent exchange in the vasa recta. While solutes can accumulate in the intersti-
tium without signicant impact on volume, water outow (solid black arrows) is tightly
matched to inow to prevent excessive swelling or shrinking of the kidney. The tight
water balance allows to reduce solute washout from the interstitium.
The NaCl gradient in the renal outer medulla is developed due to the deposition
of NaCl in excess of water. The solute is delivered by the water impermeable thick
ascending limb which actively pumps NaCl into the interstitium. At slow enough rates
of medullary blood ow the solute is not fully removed and thus starts to accumulate in
the medulla. The parallel arrangement of vasa recta also allows sodium re-circulation.
The descending blood ow is concentrated by diusive inux of NaCl and blood owing
toward the cortex in ascending vasa recta is diluted by diusive eux so that NaCl
is trapped and recycled in the medulla. This movement from ascending to descending
limbs is called countercurrent exchange.
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The interstitium is also being diluted with water drawn from descending limb, col-
lecting duct, and descending vasa recta via osmosis. However, while solutes can accumu-
late in the interstitium without a major eect on renal volume, water amount changes
could cause signicant swelling or shrinking. Thus water movement into the intersti-
tium is closely matched by water removal via vasculature. This minimizes dilution of
the hyperosmotic interstitium. Loss of water from the descending vasa recta results in
higher osmolality of blood delivered to the inner medulla and reduced volume ow which
reduces the tendency to dilute the inner medullary interstitium. The ascending vasa
recta picks up water from the interstitium due to its high osmolality and high oncotic
pressure (see Figure A.4). Thus the countercurrent exchange of water prevents blood
from diluting the inner medulla.
The osmotic gradient might be further optimized by shunting of water from descend-
ing to ascending vasa recta in vascular bundles and further reducing blood ow rate to
the deep medulla. The short loops of supercial nephrons, which make a turn in the
outer medulla may also contribute additional concentrating power. The nal segment
of the descending limb of short-looped nephrons lacks water channels and thus do not
dilute nearby interstitium while its nearby thin ascending limb continues to concentrate
the interstitium by actively pumping out NaCl.
Accumulation of urea in the renal inner medulla
As indicated above, the inner medullary osmolality can almost double during anti-
diuresis (Table A.3). The inner renal medulla contains only thin portion of the ascending
limbs of long-looped nephrons. They have little to no capacity for active NaCl transport,
thus it cannot account for the inner medullary osmolality gradient. Instead, the gradient
is driven by urea accumulation which is also achieved by a process of solute recycling
with the help of parallel ows in the vasa recta.
Normal plasma concentration of urea is small (about 5 mmol/L) and the main
purpose of urea is to transport and excrete excess nitrogen. Thus, once urea is ltered
into the renal tubules, a large portion of it is excreted with urine and another signicant
portion may be trapped in the inner medulla instead of being returned to the circulation.
The urea accumulation in the inner medulla is mainly due to a very high urea
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permeability of the medullary collecting ducts and the bottom portion of the loop of
Henle which allows its recycling within the distal portion of the nephron (Figure A.6).
Let us briey describe how this phenomenon occurs. Urea is rst ltered into the
nephron at a low concentration equal to that of plasma (about 5 mmol/L). About half
of the ltered load is reabsorbed in the proximal tubule and the rest ows down to
the bottom of the loop of Henle. The urea concentration of the ltrate increases due
to water loss in the urea-impermeable descending limb (about 15 mmol/L). At the
bottom of the loop of Henle the interstitial urea concentration is signicantly higher
luminal one (about 500 mmol/L) which together with high wall permeability leads
to urea secretion into the loop of Henle. This results in restoring almost all of the
ltrate's urea content. The remaining portion of the nephron is fairly impermeable to
urea until the very last segment, the inner medullary collecting duct, where it arrives
at very high concentrations, especially during anti-diuresis and thus signicant water
reabsorption in the collecting ducts. When the luminal urea concentration exceeds that
of the surrounding interstitium passive reabsorption from the inner medullary collecting
ducts raises interstitial gradient and drives urea secretion in the thin limbs. Thus, a
large portion of the urea load is recycled within the nephron. Normally about 15-30%
of the originally ltered urea is excreted in the urine.
Vasa recta is also highly permeable to urea and thus has a potential of washing out
the inner medullary gradient. The washout is mitigated via several pathways. First,
some of the urea is recycled between the descending and the ascending vasa recta limbs.
The blood ow to the region (the descending recta ow) is reduced by the osmotic
gradient in the outer medulla as well as shunting of water through vascular bundles.
The ascending vasa recta ow, however, is higher, especially during anti-diuresis when
water reabsorption is elevated. High urea permeability of the vasa recta equalizes the
concentration between the two limbs and thus traps some of the urea (Figure A.6).
Second, a portion of urea is picked up from the ascending vasa recta by the thick
ascending limbs. Third, in the outer stripe of the medulla high urea permeability of
thick ascending limbs and relatively attenuated eective blood ow allow urea transfer
to neighboring proximal tubules. Finally, a portion of the urea may be extracted from
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vasa recta in the outer medulla by the descending limbs of the short loops of Henle.
The importance of this last pathway is still being debated.
Remaining open questions
While the mechanisms behind outer medullary interstitial gradient have been con-
rmed via modeling and experimental data, the urine concentrating mechanism in the
inner medulla remains controversial despite decades of investigation [64]. The passive
mechanism as described above is critically dependent on tubular permeabilities to NaCl
and urea. However, mathematical predictions based on measured values of urea perme-
abilities have been unable to predict a signicant osmolality gradient. Several alternative
hypotheses have been proposed, such as the impact of anatomical proximity of dierent
tubular segments and vasculature, the eect of muscular contractions of pelvic wall, and
the role of other solutes. Another not completely understood phenomenon is the origin
of the small NaCl gradient in the inner medulla. The mathematical modeling of inner
medullary interstitial gradient remains an area of active research.
A.4 Control of ltration rate
As described above, sodium excretion is the net dierence of sodium ltration and
sodium reabsorption, both of which can be varied via intrinsic and extrinsic controls.
In the following sections we discuss major known controls of sodium and water reab-
sorption. Later, we will combine these pathways of sodium control into one picture of
the cascade of the events triggered in response to an increased sodium intake. The rst
step in sodium and water excretion process is the glomerular ltration rate (GFR). As
discussed in A.3.1, it has four primary determinants: transcapillary hydrostatic pres-
sure dierence (PG PB), glomerular ltration coecient, colloid osmotic pressure ()
at the aerent end, and the renal blood ow (Figure A.7). The eect of the latter is
seen in cases of low ow rate when the ltration equilibrium is achieved. It can be un-
derstood by deriving GFR from the following facts. First, protein is conserved during
ltration and thus QA  cA = QE  cE , where Q and c are the plasma ow rate and
protein concentration at the aerent (A) and eerent (E) ends of glomerular capillaries,
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respectively. Second, colloid osmotic pressure is almost linearly proportional to protein
concentration:  ' ac. Third, at ltration pressure equilibrium E = PG   PB. Thus,
we get
GFR = QA(1  cE
cA
) ' QA(1  A
PG   PB )
GFR varies linearly with the plasma ow rate only at low values of ow, when the
ltration equilibrium achieved, which is often observed in rat kidneys or severe cases of
renal dysfunction in human kidneys.
Figure A.7: Controls of glomerular ltration rate (GFR). Note that the resistance con-
trol on both ends of the ltration process allows for a exible control of perfusion
pressure and blood ow. Positive feedback is shown by solid-ended arrows, negative
feedback is shown by at-ended arrows .
Out of the four determinants of GFR, the perfusion pressure PGC and renal blood
ow (RBF) have the most potential to aect it. They in turn can be modulated by
changing aerent and eerent arteriolar resistances. Vasoconstriction of aerent arteri-
oles is mediated via an increase of intracellular calcium concentration, which happens
in response to gating of mechanosensitive channels producing membrane depolariza-
tion and activation of calcium-dependent channels. There is a multitude of mechanical,
neural, extrinsic and local hormonal vasoconstrictor and dilators, which may aect one
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or both arterioles as well as excite or inhibit other pathways of control. Some of the
controllers are shown in Figure A.8. Such vast number of controllers allows kidney
to regulate both ow and perfusion pressure over a large range of renal arterial pres-
sures. Additional exibility may come from the unequal response of the cortical versus
medullary arterioles to the same stimulants [68]. Thus, despite large variations in arte-
rial pressure, sodium and water intake, and volume uctuations, GFR and RBF remain
within narrow limits in most physiological circumstances, and in particular in early
hypertension.
Figure A.8: Major controls of renal arteriolar resistances. Many pathways, especially
the role of endothelial factors such as prostaglandins, endothelin, and nitric oxide, are
not shown due to complexity. They can, however, play an important role. For example,
angiotensin II activates endothelial release of prostaglandin PGE2 and nitric oxide in
the aerent but not the eerent arteriole, which blunt the vasoconstriction caused by the
angiotensin II. Thus angiotensin II-mediated vasoconstriction of the eerent arteriole is
10-100 stronger than that of aerent arteriole. Positive feedback is shown by solid-ended
arrows, negative feedback is shown by at-ended arrows.
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Glomerular membrane permeability is also under neurohumoral control. Mesangial
cells covering the glomerular capillaries can relax or constrict based on the input from
atrial natriuretic peptide, sympathetic stimulation, angiotensin II, or tubuloglomerular
feedback. Changes in the contraction of the mesangial cells lead to changes in the
membrane permeability. However, the signicance of membrane permeability control is
still being debated.
A.4.1 Renal autoregulation
The kidney is one of the most ecient organs (along with brain and heart) in its au-
toregulation ability - the ability to maintain relatively constant blood ow across a
wide range of perfusion pressures. In addition to blood ow, the kidney also autoregu-
lates glomerular ltration rate which is a consequence of the autoregulation of ow and
glomerular capillary pressure. Autoregulation of blood ow requires parallel changes in
resistance with changes in perfusion pressure. When perfusion pressure is increased, the
predominant resistance change comes from the constriction of the aerent arterioles and
slight dilation of the eerent arterioles. Together these changes dampen the increase in
blood ow and glomerular capillary pressure responses.
Autoregulation is mostly present in the cortical circulation only. The medullary cir-
culation shows little autoregulatory response as was demonstrated in studies by Cohen
et al [18] and Mattson et al [69]. Autoregulation of renal blood ow is intrinsic to the
kidney and is largely independent of circulating hormonal or neurogenic factors, as it
persists in an isolated and a denervated preparations. There are two major components
of the renal autoregulation: the myogenic mechanism and the tubuloglomerular feed-
back mechanism. The two components are not mutually exclusive and are capable of
modulating each other as they act on the same eector site, the aerent arteriole.
The ability of smooth muscle around a vessel to contract and relax in response to
vascular wall tension is termed a myogenic response. The constricting force has pas-
sive and active components, the latter sensitive to the stretch of the vessel. A myogenic
response of autoregulation occurs very rapidly, with full response in 3-10 seconds. It is
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observed in the aerent arteriole, as well as arcuate and interlobular arteries. The eer-
ent arterioles seem to have only passive component as they dilate in response to increase
perfused pressure (in the absence of other competing mechanisms). The autoregulatory
threshold can be reset in response to various conditions. In particular, in some animal
models of hypertension much higher pressures are required to invoke vasoconstrictor
response in the aerent arteriole.
The tubuloglomerular feedback (TGF) mechanism alters the aerent arteriolar
resistance in response to sensed sodium ow (often termed as "sodium delivery") at
the macula densa site of the same nephron. The main purpose of TGF is to maintain
relatively constant sodium ow to the distal tubule. The increased sodium perfusion of
the macula densa causes reduction in nephron's glomerular blood ow and GFR, as well
as the release of renin which initiates longer term hormonal response (see the following
section). Certain substances such as nitric oxide and angiotensin II aect sensitivity of
TGF. Over the long term exposure to a new sodium delivery rate TGF system resets
to a new operating point.
A.5 Control of sodium reabsorption
There are two major steps to tubular sodium reabsorption. First step is the bulk reab-
sorption which happens in the proximal tubule and thick ascending limb. It reabsorbs
nearly 90% of ltered sodium. Second step is the ne-tuning of reabsorption which
happens in the distal tubule and collecting ducts. Control of sodium reabsorption is
complex and involves a variety of interdependent neural and hormonal factors [14]. The
summary of all reabsorption steps and their major controllers are given in Table A.4,
the details are discussed below.
The major factor determining the rate of tubular sodium reabsorption is the hormone
aldosterone. It stimulates the sodium reabsorption by the distal tubule and collecting
ducts. When aldosterone is completely absent, approximately 2% of the ltered sodium
is excreted. In contrast, when the plasma aldosterone is high, essentially all the sodium
reaching the distal tubule and collecting ducts is reabsorbed. Aldosterone's eect on
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Segment Reabsorbed sodium, Major controllers
% of the ltered load
The proximal tubules 60% SNS(+), AngII()
The ascending limb of Henle 30% Vasopressin(+), AngII(-)
The distal tubules and collect-
ing ducts
8..10% Aldosterone(+), Vaso-
pressin(+)
Table A.4: Sodium reabsorption rates within a human nephron and factors that stim-
ulate (+) or inhibit (-) the reabsorption. Ranges of values show variation between
natriuresis (large sodium loss) and anti-natriuresis (restricted sodium loss). Note that
the control of reabsorption resides in the distal nephron where the ne-tuning is per-
formed. AngII, angiotensin II; GFR, glomerular ltration rate; GTB, glomerulotubular
balance; SNS, sympathetic nerve stimulation
sodium transport is delayed by a few hours since there is a sequence of events (changes
in gene expression and protein synthesis) that needs to take place in order to insert
active sodium transport channels into the tubular membrane.
The production of aldosterone is a part of the of the hormonal complex termed the
renin-angiotensin-aldosterone system (RAAS) (see Figure A.9). As the name
implies it is a sequential hormone production, starting from the secretion of renin,
which is also the limiting factor in the entire chain. Renin is an enzyme secreted by the
juxtaglomerular cells. Once in the blood stream, it undergoes several conversions that
lead to the production of angiotensin II, which then stimulates aldosterone production
by the adrenal cortex. In addition to the systemic circulating RAAS, there are separate
organ-specic renin-angiotensin systems in tissues such as the kidneys, brain, and the
heart.
There are at least four distinct inputs that modulate renin production: the renal
sympathetic nerves, intrarenal baroreceptors, the macula densa, and angiotensin II. The
renal sympathetic nerves directly innervate the juxtaglomerular cells, and an increase
in their activity stimulates renin secretion. Since the juxtaglomerular cells are located
in the walls of the aerent arterioles, they can sense wall stretch due to changes in
pressure and thus function as intrarenal baroreceptors. An increase in blood pressure
leads to a reduction renin secretion. The juxtaglomerular cells also receive input from
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the macula densa so that an increased sodium concentration at the macula densa results
in a reduction of renin secretion. Angiotensin II (either systemic or intrarenal) reduces
renin secretion, providing a negative feedback to RAAS.
Figure A.9: Summary of the major components of the renin-angiotensin-aldosterone
system. Positive feedback is shown by solid-ended arrows, negative feedback is shown
by at-ended arrows.
Angiotensin II (AngII) exerts many eects on both the entire cardiovascular system
and the renal function. AngII is produced not only in plasma but also within kidneys
themselves. The concentration of intrarenal AngII might exceed the plasma concen-
tration and play a more signicant role in the regulation of renal function. We have
already described the AngII eect on the stimulation of the secretion of aldosterone and
the constriction of arterioles. AngII also has a potent and complex eect on proximal
sodium reabsorption. At high doses of AngII the reabsorption in the proximal tubule is
inhibited, and at low doses it is stimulated. AngII also blunts sodium reabsorption in
the thick ascending limb.
Changes in sympathetic input and the RAAS are the most important means of
regulating sodium reabsorption. However, there are many other modulators, some of
which are outlined below:
 Independently of the neurohumoral control, there is an intrarenal phenomenon
of glomerulotubular balance wherein changes in glomerular ltration rate are
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balanced by equivalent changes in proximal reabsorption. This results in a con-
stant fractional reabsorption of uid and NaCl over a wide range of ltration rates.
The mechanisms responsible for this phenomenon are subject of active research.
 Vasopressin is one of the strongest modulators of transepithelial NaCl transport
in the thick ascending limb. It activates apical Na-K-Cl co-transport, apical K+
channels and basolateral Cl channels within minutes. It also increases sodium
channel presence in the distal nephron by slowing down their natural removal and
degradation processes. Sustained increases in circulating vasopressin result in a
long-term eect of cell hypertrophy and almost doubling of active NaCl transport.
Vasopressin also exerts an anti-natriuretic eect on collecting ducts and has a
synergistic eect on sodium transport when combined with aldosterone.
 Intrarenal production of dopamine plays an important role in inhibition of prox-
imal sodium reabsorption. The mechanisms are still not clear but it seems to both
reduce the reabsorption itself and blunt the stimulating eect of AngII.
 Atrial natriuretic peptides inhibit release of renin, inhibit actions of AngII that
promote sodium reabsorption, and inhibit sodium reabsorption in the medullary
collecting duct.
A.6 Control of water reabsorption
Water is reabsorbed passively by osmosis until distal portions of the nephron where wa-
ter permeability of the tubular walls is controlled independently of sodium. The major
determinant of this permeability is vasopressin. It stimulates the insertion of aquaporin
channel into the luminal membrane of the collecting ducts. It also vasoconstricts the
descending vasa recta, limiting the medullary blood ow and thus limiting the washout
of the medullary osmolality gradient. Thus, in the presence of a high plasma concen-
tration of vasopressin water reabsorption is increased both due to high permeability
and high osmotic gradient drawing the water into the interstitium, resulting in water
conservation.
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Vasopressin is a peptide synthesized by neurons in the hypothalamus. There are two
main triggers of vasopressin secretion. First is the osmoreceptor signal which monitors
cell volume and thus changes in plasma osmolality. Second trigger comes from the
cardiopulmonary baroreceptors which monitor venous, atrial, and arterial pressures.
Figure A.10 shows an example of vasopressin-related pathways triggered in response
to an increased plasma osmolality, which may occur, for instance, during high sodium
intake. All mechanisms involved in this diagram are fast acting which explains why
changes in plasma osmolality are almost impossible to observe experimentally. An in-
crease in plasma osmolality causes osmotic water shift out of the cells, restoring the os-
molality to normal, but shrinking the cells and increasing the extracellular uid volume.
Both of the eects trigger vasopressin release which leads to reduced water excretion
and increased sodium excretion. This causes a reverse osmotic shift of water back into
cells, restoring the homeostatic balance. Note, that vasopressin's control of sodium ex-
cretion is fairly limited and would be further attenuated if a large amount of sodium is
ingested in equal portions with water.
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Figure A.10: Vasopressin-related pathways by which plasma osmolality and extracellular
uid volume are restored in response to high sodium intake. Positive feedback is shown
by solid-ended arrows, negative feedback is shown by at-ended arrows.
Appendix B
Sensitivity analysis
The hemodynamic pattern generated by a mathematical model of long-term blood pres-
sure is aected by a high degree of uncertainty in both its structure and its parameters.
This is due to the high inherent variability of a biological system, population variability,
the complexity and unknown nature of the phenomena involved, and the experimental
limitations. Therefore, any interpretation of the model's predictions should acknowledge
this uncertainty. Sensitivity analysis techniques are often employed for this purpose.
B.1 Local sensitivity analysis
Consider a dynamical system
dZ
dt
= F (Z(t); C) (B.1)
where Z is a state vector, C is a vector of parameters, and F is suciently continu-
ous. The dynamical behavior of the system (B.1) in the vicinity of a solution Z can
be studied via the linearization along this solution, which is given by the variational
equation
dZ
dt
= DZF (Z(t); C)Z:
Similarly, to study the impact of the change in a parameter Cj on the state Zi one
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can dene a sensitivity measure Sij as
Sij(t; C)jC=C0 =
@Zi(t; C)
@Cj
jC=C0
where C0 is the vector of original values parameters that is being perturbed. The
sensitivity measures then can be computed by dierentiating each equation of (B.1)
with respect to each parameter:
dSij
dt
=
@
@Cj
Fi(Z;C) (B.2)
and solving (B.2) together with the state equations (B.1).
In practice, the sensitivity measure is often normalized so that the relative sensitivity
of the output could be assessed across model parameters:
Sij =
@Zi
@Cj
Cj
Zi
:
The derivative-based approach to sensitivity is an ecient approach in computa-
tional time and has been widely accepted in the literature. However, derivatives are
only informative at the base point where they are computed and do not aid in the ex-
ploration of the rest of the parameter space. Thus this approach is of limited value when
both the model inputs and outputs are uncertain and when the model is of unknown
linearity. Even if variation in the model's parameters and states can be taken into an
account by dening Sij =
@Zi
@Cj
Ci
Zj
(where 's are the standard deviations), the approach
remains local in the sense that the eect of variation in one parameter is studied while
all others are xed at their nominal values. Thus the nonlinear interactions between
the parameters are not estimated in the derivative-based approach.
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B.2 Global sensitivity analysis
Global approaches estimate the eect of a parameter when all the others are varying,
enabling the identication of parameter interactions in nonlinear and non-additive mod-
els. These approaches are usually computationally more expensive. An elegant global
sensitivity approach [92] is based on variance-based measures and has multiple uses for
model simplication, identication of key parameters and model calibration.
Let us restate the original system (B.1) from a dierent perspective:
Y = f(X) = f(X1; : : : ; Xn)
where Y is the vector of model's outputs and X is a vector of input variables. Both
inputs and outputs have a wider meaning then the states and parameters in the above
discussion. For example, Y can be dened as a maximum of the solution of (B.1) or
its steady state or as any other feature of interest to a researcher. The model's input
factors consist of parameters with nonnull uncertainties and can include other entities,
such as the initial values. The function f is usually not dened explicitly and in general
refers to a procedure that one must do to obtain an output from the given inputs. The
goal of the global sensitivity analysis is to apportion the uncertainty in the model's
ouput Y to the uncertainties in its input factors X.
The function f(X) can be written as a sum of terms of increasing dimensionality,
where each rst-order term is a function of single variable, each second-order term is a
function of two variables, etc:
f(X) = f0 +
X
i
fi(Xi) +
X
i<j
fij(Xi; Xj) +
X
i<j<k
fijk(Xi; Xj ; Xk) + : : : (B.3)
where f0 is a constant. This decomposition is not unique. However, if each term of
(B.3) is chosen with zero average, then the decomposition is unique and the terms are
pairwise orthogonal. Moreover, the terms are given by the conditional averages of f(X):
fi(Xi) = E(Y jXi)  E(Y )
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fij(Xi; Xj) = E(Y jXi; Xj)  fi(Xi)  fj(Xj)
: : :
If the input factors are not correlated, then it is possible to decompose the variance of
f(X) as V (Y ) =
P
i Vi +
P
i<j Vij +
P
i<j<k Vijk +   + V12::n where:
Vi = V (fi(Xi)) = V (E(Y jXi))
Vij = V (fij(Xi; Xj)) = V (E(Y jXi; Xj))  Vi   Vj (B.4)
: : :
The fi(Xi) are referred to asmain eects ofXi, and the higher order terms are referred
to as interactions.
B.2.1 Main eects
The main eect of Xi is a measure of sensitivity of Y to an individual input Xi. An
intuitive way to dene it would be to say that it is V (E(Y jXi)), the expected amount
of variance that would be removed from the output if Xi is xed at some value (within
its range of uncertainty). A more rigorous approach starts by considering how the
uncertainty of Y would be aected in the factor Xi is xed at a particular value x.
Then the conditional variance V (Y j Xi = x) could be considered as a measure of
the remaining variance in Y , or the relative importance of Xi, in relation to the total
unconditional variance in the output V (Y ). This measure can be further improved by
taking the average over all possible values of x: EXi(V (Y j Xi)). Moreover, by the law
of total variance (see proof at the end of the section):
E(V (Y j Xi)) + V (E(Y j Xi)) = V (Y ):
156
Hence, a large V (E(Y j Xi)), will imply that Xi is an important factor. Thus the
rst-order sensitivity index of Xi on Y is dened as:
Si =
V (E(Y j Xi))
V (Y )
Si is a number always between 0 and 1.
The rst-order sensitivity index can indicate whether eorts at reducing uncertainty
in Xi can greatly reduce the uncertainty in the output. Thus this measure is useful
prior to conducting a calibration experiment on a given input. The value 1   Si can
be interpreted as the minimum value of the expected loss when f(X) is approximated
by E(Y jXi). The higher Si, the better the approximation. However, the smaller values
of Si do not necessarily imply the unimportance due to potential nonlinearities in the
model.
Note, that the rst-order sensitivity index also follows from (B.4). In a similar
fashion, higher-order sensitivity indices can be dened for interaction terms:
Sij =
Vij
V (Y )
Sijk =
Vijk
V (Y )
: : :
Theorem 1. The law of total variance: V (Y ) = E(V (Y jX)) + V (E(Y jX)).
Proof:
We know that (a): V (Y ) = E(Y 2)  [E(Y )]2 by denition, (b) E(Y ) = E(E(Y jX))
(the law of total expectation), and (c) E(X + Y ) = E(X) + E(Y ) . Then we have
V (Y )
(a)z}|{
= E(Y 2)  [E(Y )]2
(b)z}|{
= E(E(Y 2jX))  [E(E(Y jX))]2
(a)z}|{
= E(V (Y jX) + [E(Y jX)]2)  [E(E(Y jX))]2
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(c)z}|{
= E(V (Y jX)) + E([E(Y jX)]2)  [E(E(Y jX))]2
(a)z}|{
= E(V (Y jX)) + V (E(Y jX))
B.2.2 Total eects
While studying higher-order sensitivity measures for the input factors interactions (e.g.
Sij) can be of value, the second step after computing main eects is usually to compute
total eects instead. The total eect of the input factor Xi is linked to E(V (Y jXi)),
which is the expected amount of output variance that would remain unexplained if only
Xi is varying over its uncertainty range, while all other inputs are xed. Thus the total
sensitivity index (or total eect) is
STi =
E(V (Y jXi))
V (Y )
:
Another interpretation of the total sensitivity index STi is that it is a sum total of all
sensitivity indices involving Xi (assuming orthogonality), for example if there are total
of three input factors:
ST1 = S1 + S12 + S13 + S123:
The total sensitivity indices are used in identifying input factors which are unessen-
tial either singularly or in combination with others. These input factors can thus be
xed at any value within their range and thus simplify the model. Also STi Si measures
how much Xi is involved in interactions with other input factors.
B.3 An excitation-adaptation example
Let's consider an excitation-adaptation system:
_y1 =
I   (y1 + y2)
E
; y1(0) = 0 (B.5)
_y2 =
I   y2
A
; y2(0) = 0 (B.6)
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where A is the adaptation time constant, E is the excitation time constant, and I
is the stimulus function which is assumed to be a step function: I(t) = 0; t  0 and
I(t) = I1; t > 0.
The solutions and behavior of the system's solutions are well-understood, so we
will use them to compute sensitivities directly, even though in a general application
one would have to solve the original system of dierential equations numerically. The
solutions of (B.5)-(B.6) are:
y1 =
I1A
A   E (e
 t=A   e t=E ) (B.7)
y2 = I1(1  e t=A) (B.8)
One can observe that the steady state of y1 is 0, i.e. after a short period of excitation
it returns to its initial state. The magnitude of the deviation is inuenced by the
system's parameters: A, E and I1 (see Figure B.1). Let's employ both local and
global sensitivity analysis techniques described above to the question of sensitivity of
this deviation to system's parameters.
Let's assume the following uncertainties on the parameters I1  N(5; 0:5), E 
N(0:5; 0:1) and A  N(1; 0:1). Let us also choose the following time points at which
the global measures of sensitivities to be computed1 : t = 0:1; 0:2; 0:5; 0:7; 1; 2; and 4.
The results of the local sensitivity analysis are summarized in Figure B.2. We can
distinguish roughly three time periods where sensitivities switch roles: the excitation
period (t < 0:5), maximum (0:5 < t < 1:6) and the adaptation period (t > 1:6). During
the excitation period E is the most sensitive as compared to the other time intervals
(Figure B.2, left panel). It is also relatively more sensitive than A but less sensitive than
I1 during the excitation period and becomes the least important of all three parameters
afterwards (Figure B.2, right panel). The stimulus magnitude I1 is most sensitive up
to the adaptation period during which the adaptation time constant A takes the lead.
The results of the global sensitivity analysis are summarized in Figures B.3 and B.4.
The total eects (Figure B.3) show that none of the parameters can be considered as
1 SimLab, version 2.2.1 was used for the computation of global sensitivity indices.
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Figure B.1: Solution y1 of (B.5)-(B.6) for I1  N(5; 0:5), E  N(0:5; 0:1) and A 
N(1; 0:1) at their mean values. If a sample of parameters chosen from the parameter
space, then the distribution of y1 can be computed at a given time point. The error
bars show the standard deviations of these distributions.
noninuential for the entire time period, but during the excitation period the adaptation
time constant A could be xed if one wanted a simpler model of the solution at the early
stage. Similarly, during the adaptation period total eect of the excitation time constant
becomes small and thus it can be considered noninuential. The main eects (Figure
B.4) show that the stimulus signal I1 makes the largest contribution to the uncertainty
of the solution during the middle stage where it reaches its maximum. Small main
eects for the time constants would not necessarily mean that they do not contribute
as well. However, in this case the dierence between total eects and main eects
are small indicating that there are no signicant interaction terms and thus the time
constants indeed contribute little to the variation of the solution around its maximum.
The conclusions of local and global sensitivity analysis agree well in this example.
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Figure B.2: Left panel: Local sensitivity measures of y1 (y-axis) as functions of time
(x-axis): @y1@A (solid line),
@y1
@E
(dashed line), and @y1@I1 (dotted line). Right panel: Local
normalized sensitivity measures of y1:
@y1
@A
A
y1
(solid line), @y1@E
E
y1
(dashed line), and
@y1
@I1
I1
y1
(dotted line).
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Figure B.3: Total eects (y-axis) of parameters A (diamond markers), E (square
markers), and I1 (triangle markers) as functions of time (x-axis).
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Figure B.4: Main eects (y-axis) of parameters A (diamond markers), E (square
markers), and I1 (triangle markers) as functions of time (x-axis).
Appendix C
Time scale separation example
Consider a highly simplied version of the model presented in Chapter 2: a circulatory
model with two regulatory mechanisms, control of sodium excretion and arterial resis-
tance, as we have described in [6]. The following analysis demonstrates the time scale
separation technique for calculation of the quasi-steady states of the system.
The simplied system presented in [6] with the notation adjusted to the one pre-
sented in Chapter 2 is:
CA
dPA
dt
= CO  PA   PS
RAS
  PA   PR
RAR
CS
dPS
dt
=
PA   PS
RAS
  PS   PV
RV S
CV
dPV
dt
=
PS   PV
RV S
+
PR   PV
RV R
  CO
dVB
dt
= kV T (FSI   FSE)
SE
dFSE
dt
+ FSE = FSI
N
dRAS
dt
+RAS = RAS;0(1 + kN (FSI   FSI(0))(a  1))
where CO = PV  p0kFS , FSI = JNaCl,I-P is the sodium intake rate, FSE is the sodium
excretion rate, and a = AngIIAngII0 is the normalized AngII plasma concentration. See [6]
for details on the parameters kFS , kV T , p0, SE , N , and RAS;0.
The conservation of total blood volume eliminates one of the pressure equations and
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dictates:
VB   VUnstr = CAPA + CSPS + CRPR + CV PV
The system can be simplied by dening VStr = VB   VUnstr and replacing the
equation for PS by the one for PR:
CA
dPA
dt
= CO  PA   PS
RAS
  PA   PR
RAR
Cr
dPR
dt
=
PA   PR
RAR
  PR   PV
RV R
Cv
dPV
dt
=
PS   PV
RV S
+
PR   PV
RV R
  CO (C.1)
dVStr
dt
=  VStr   VStr(0)
SE
+ kV T (FSI   FSI(0))
dRAS
dt
=   1
N
(RAS +RAS;0(1 + kN (FSI   FSI(0))(a  1)))
with
VStr = CAPA + CSPS + CRPR + CV PV :
The initial values for the variables in (C.1) are assumed to be their normal values:
Pi(0) = Pi;0; i = A;S; V
VStr(0) = VB(0)  VUnstr = VStr,0
RAS(0) = RAS;0
The goal is to rewrite the system (C.1) in the explicit form with two time scales.
Let us introduce dimensionless variables
pa =
CSPA
VStr,0
; pr =
CSPR
VStr,0
; pv =
CSPV
VStr,0
ras =
RAS
RV R
; v =
VStr
VStr,0
; s =
t
SE
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and dimensionless parameters
bp0 = CSp0
VStr,0
ca =
CA
CS
; cr =
CR
CS
; cv =
CV
CS
rar =
RAR
RV R
; rvs =
RV S
RV R
;  =
RAS;0
RV R
; bkFS = kFS
RV RbkN = kNFSI;0; bkV T = kV TFSI;0SE
VStr,0
; sin =
FSI
FSI;0
 =
CRRV R
SE
; bN = SE
N
Note that angiotensin II level, a(t) is already dimensionless.
Then we can rewrite (C.1) in dimensionless form as

dpa
ds
=
cr
ca

1bkFS (pv   bp0)  1ras ((1 + ca)pa   v   crpr   cvpv)  1rar (pa   pr)


dpr
ds
=
1
rar
(pa   pr)  (pr   pv)

dpv
ds
=
cr
cv

1
rsv
(v   capa   crpr   (cv + 1)pv) + pr   pv   1bkFS (pv   bp0)

(C.2)
dv
ds
= 1  v + bkV T (sin   1)
dras
ds
=  bN (ras   (1 + bkN (sin   1)(a  1)))
It can be seen from Table C.1 that the functions on the right-hand side of the (C.2)
are of approximately the same order.
Variable (bold) or Parameter Order
ras; rar;  10
v;pa; cv; rvs; rvr;bkFS ; sin; a 1
pr;pv; ca; cr;bkN ; bN 0.1bp0;bkV T 0.01
Table C.1: Estimated magnitudes of dimensionless parameters and variables.
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Thus there are two groups of variables in the system: fast variables z =
0BBBB@
pa
pr
pv
1CCCCA
and slow variables y =
0B@ v
ras
1CA. And so (C.2) can be written as:

dz
ds
= A1(y)z +A2(y); z(0) = z0
dy
ds
= B1y +B2; y(0) = y0 (C.3)
Setting  = 0 we obtain the quasi-steady states ys and zs:
0 = A1(ys)zs +A2(ys) (C.4)
dys
dt
= B1ys +B2; ys(0) = y0 (C.5)
Assuming that sodium intake and angiotensin input are constants we can obtain the
quasi-steady states in the explicit form:
ys =
0B@ 1 + bkV T (sin   1)(1  e s)
(1 + bkN (sin   1)(a  1)(1  e bNs))
1CA (C.6)
zs =  A 11 (ys)A2(ys)
In order to obtain the fast solutions, we rewrite system (C.3) in the fast time scale
 = t and set  = 0:
dz
d
= A1(y)z +A2(y)
!0) dzf
d
= A1(y0)zf (); zf (0) = z0   zs(0)
dy
d
= (B1y +B2)
!0) dy
d
= 0
Note that the fast subsystem is linear and thus has only one solution. It can be
checked numerically that for the physiologically relevant parameters all eigenvalues of
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A1(y0) are negative and thus the fast solution is always stable. Therefore, the Tikhonov
theorem applies and the long-term solutions of the original system (C.1) can be approx-
imated by the quasi-steady states (C.6).
